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ABSTRACT OF THE DISSERTATION
SYSTEMATIC COMPARISON OF PRE-TREATMENT PARAMETERS IN
FORENSIC HAIR ANALYSIS AND INVESTIGATING HAIR-DRUG
INTERACTIONS
by
Jennett Chenevert Aijala
Florida International University, 2020
Miami, Florida
Anthony P. DeCaprio, Major Professor
Forensic toxicological analysis for the purposes of protecting human health and
supporting criminal justice activities can be achieved, in part, by means of analysis of
human head hair for detection of abused substances. Hair is considered an alternative
sample matrix (compared to blood and urine) because of persistent interpretive challenges
caused by a lack of standardization in analytical approaches and poor understanding of the
biases resulting from physicochemical interactions between major hair components (e.g.,
melanin) and drugs of abuse. Some of the uncertainty regarding optimal techniques for the
pre-treatment of hair specimens results from the unknown nature of the interactions
between drugs and hair components, in particular melanin. Thus, the second focus of this
work was to study these interactions with select drugs and melanin by UV/Visible
spectroscopy. Another source of uncertainty is attributed to the lack of standardization in
the analytical approach to hair testing. As a complex solid sample matrix, hair requires pretreatment measures including decontamination, homogenization, and extraction to remove
drug from the hair components to allow for analysis. Optimizing these pre-treatment

vii

parameters is essential for accurate toxicological analysis of this matrix. Thus, a major
focus of this work was to conduct a comprehensive comparison of the efficacy of
decontamination and extraction variables by means of statistical design of experiments
(DoE).
Major findings of this work were a minimum of four consecutive washes were
necessary for the decontamination of hair and solvent swelling of the matrix resulted in the
highest extraction of the five analytes under study. The other major conclusion of this work
was the interaction between eumelanin and drugs is a result of ionic interactions and van
der Waals forces. Additionally, association constants between drugs and eumelanin were
determined to provide additional insight into the strength of interactions between drugs
with different physicochemical properties and eumelanin.
These findings will impact the forensic science community by contributing to a body
of research aimed at determining the most effective method(s) for decontaminating hair
samples for forensic analysis, the subsequent isolation of drugs from hair, and by
investigating the interactions between melanin and select drugs of abuse.
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1. INTRODUCTION
1.1 Statement of the Problem
Human head hair has been used as an alternative matrix in forensic toxicology for
several decades to overcome some of the challenges and limitations associated with the use
of blood and urine for monitoring an individual’s exposure to use or abuse of xenobiotic
substances. Hair testing is an excellent method for determining drug use history because
the window of detection is significantly longer than in blood and urine, allowing for the
detection of drugs when traditional testing may fail. While clearly useful for long-term
drug detection, hair analysis does have technical and interpretive challenges. As a complex
solid sample matrix, hair requires specific pre-treatment measures, including washing,
cutting and/or pulverization, and some type of extraction procedure to remove the drug
from the hair matrix components to allow for analysis. Optimizing the pre-treatment steps
in forensic toxicological analysis of hair and the subsequent extraction of analytes is
essential to accurately identify and quantify drugs present in a hair sample. The Society of
Hair Testing (SoHT), the only governing body for hair testing to date, has made
recommendations on protocols, although they provide only general guidelines for analysis.
While numerous methods and a large literature base exists for forensic hair testing, such
methods have not been systematically compared with regard to performance. Thus, a major
aim of the present work was to develop optimized methods for the pre-treatment and
extraction of hair samples to support recommendations toward the standardization of
forensic toxicological hair analysis.
Hair is considered an alternative matrix in the field of forensic toxicology since it is not
as well studied and understood as more classic matrices like blood and urine, especially in
1

regard to the mechanisms by which drugs become associated with the matrix and
subsequently held there. Nevertheless, a consensus has emerged that there are three routes
of exposure of hair to xenobiotics.1,2,11–13,3–10 The first is direct incorporation into hair from
blood that contains the drug as it grows from the follicle. Alternatively, substances can
become incorporated into hair through contact with drug-containing sweat or sebum on the
scalp. Finally, drug-containing aerosols or smoke in an individual’s environment can lead
to the deposition of drug onto the surface of the hair with subsequent incorporation. While
there is a consensus regarding routes of exposure, the exact mechanism by which
xenobiotic substances remain on and/or in the hair has not been studied extensively and is
poorly understood. The ambiguity of the nature and mechanism of the association between
drug and hair components has resulted in criticisms of the routine use of hair as a biological
matrix for toxicological analysis.7 Therefore, the second major aim of the present work was
to study the nature of the forces responsible for the interactions between components of the
hair matrix and select drugs of abuse.
1.2 Rationale for Research
Contemporary forensic toxicology places high value on validated analytical methods
for the qualitative and quantitative determination of drugs of abuse in various matrices. At
present, hair is considered an alternative matrix as there are still significant methodological
and interpretive challenges that must be addressed. Thus it is important to establish
methods for the analysis of drugs of abuse in hair under conditions that maximize the
amount of drug that can be isolated from the hair matrix for analysis without also including
any amount of drug that is superficially associated with hair structures as a result of external
contamination. Current methods may not be effective in removing all trace of drugs and
2

their metabolites from the surface of hair before extracting drug from the matrix nor in
extracting the total drug content of the cortex, as the analytes may be associated with the
biopolymers present in hair, necessitating a re-evaluation of current techniques. Therefore,
more extensive knowledge is required regarding pre-treatment parameters in hair analysis
and the mode of interaction between drugs and the components of the hair matrix. Each
subtask of the present research was designed to address a specific challenge associated with
using hair as a matrix for toxicological analysis.
1.2.1 Task 1 – Preparation of incorporated/entrapped, single analyte hair reference material
(HRM).
Several varieties of reference material have been developed for use in hair analysis, the
two most common being incorporated/entrapped HRM and authentic HRM. Incorporated/
entrapped HRM is prepared by soaking blank hair in an analyte-containing aqueous buffer.
Authentic HRM is derived from individuals who have been exposed to an analyte and
whose hair has been decontaminated and tested with a quantitative, validated analytical
method. While authentic HRM has the advantage of representing real-world samples, these
materials often contain more than one analyte and there is no means to control the
concentration along the length of the strands, which may vary as a result of inconsistent
use by the individual. Incorporated/entrapped HRM is advantageous because the amount
of drug contained in the material is dependent on the known quantity of drug added to the
incorporation buffer. In contrast, in authentic HRM the amount of drug in the material is
dependent on the variable quantities of drug actively used by the group of individuals
sampled for its preparation. In the present work, incorporated/entrapped HRM was used as
the amount of drug in the matrix is better controlled, and this this material was prepared to
3

contain a single analyte at a time for amphetamine, cocaine, morphine, diazepam, and Δ9tetrahydrocannabinol.
1.2.2 Task 2 – Systematic comparison of hair decontamination parameters via 24
fractional factorial block design.
Hair requires several pre-treatment steps before it can be analyzed for its drug content;
these steps include segmentation, decontamination, homogenization, extraction, and
purification.6 While the approaches to pre-treatment of hair for forensic toxicological
analysis are highly variable, the process of decontaminating the surface of hair includes a
host of variables in itself. Thus, in the present research, additional attention was given to
parameters that often differ between decontamination protocols, including the identities of
the organic and aqueous solvent/solutions employed to wash the hair, the number of
consecutive washes applied to each sample, the amount of time the hair is exposed to the
wash solvent/ solution, and the order of washes applied. Discrete levels of these parameters
were applied in a systematic way, using a 24 fractional factorial block design. Subsequent
ANOVA and Tukey’s Honestly Significant Difference (HSD) testing were used to indicate
if there were any significant differences in the efficacy of the wash parameters and which
wash parameters correlated to those differences, respectively.
1.2.3 Task 3 – Systematic comparison of extraction parameters in forensic hair analysis
via a 23 full factorial design.
In addition to the decontamination parameters under study, it was important to consider
the effect of other pre-treatment steps on the efficacy of the preparation of hair for
toxicological analysis. These parameters include the size of the homogenized hair particles,
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the amount of extraction agent the hair samples are exposed to, and the amount of time the
hair samples are exposed to the extraction solvent. A 23 full factorial design was used to
systematically compare discrete levels of these parameters to determine if any factor, or
combination of factors, had a significant effect on the extraction efficiency.
1.2.4 Task 4 – Probing physicochemical interactions between drugs of abuse and
eumelanin.
Although hypotheses have emerged regarding the means by which drugs become
incorporated, entrapped, or associated with the hair matrix, little is known about the
mechanisms associated with the retention of drugs in the matrix. The physical and chemical
properties of drug substances, specifically lipophilicity, alkalinity, chemical structure, and
affinity to major hair components such as melanin, have been suggested to influence their
incorporation and retention in hair.3 Additional properties of the matrix itself, such as
variable rates of growth, porosity, melanin content, chemical treatment, and external
contamination, can influence drug incorporation and retention.14 Incorporation and
retention of substances in hair may, in theory, be the result of non-covalent interaction,
such as ionic binding, H-bonding, van der Waals forces, and hydrophobic interactions,
and/or to covalent binding with hair components.4,15,16 An understanding of these
interactions would provide insight into the incorporation mechanisms of drugs into hair,
hair color biases that may exist in current testing schemes, and effective methodology for
extracting these substances for analysis. Probing of these interactions was conducted using
UV/Vis spectroscopy in the present work.
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1.3 Significance of the Study
Forensic toxicologists routinely examine blood and urine samples as reliable sources
of information about an individual’s drug use for testimony given in legal proceedings.
However, drugs of abuse have a relatively short window of detection; typically a few hours
up to a few days.3 Hair can be used to provide a longer window of detection and a temporal
profile of drug use for an individual, because it can be segmented to represent different
growth periods. While hair testing is useful for historical information regarding drug use,
it is necessary to address major challenges in hair testing to improve the consistency of
results across laboratories by standardizing hair pre-treatment conditions and to provide
additional insight into the mechanisms by which drugs are retained in hair to understand
how to reliably recover analytes for routine analysis.
The present research compared the impact of various pre-treatment parameters
commonly used in forensic toxicological analysis in human head hair on the recovery of
the isolated substances in order to make recommendations for standardized methodology.
Additionally, the research investigated the physicochemical mode of interaction between
eumelanin and select drugs of abuse by spectroscopic approaches. Consequently, the
potential for bias may be minimized as standardized methods are established and the mode
of interaction between hair matrix components and analytes is elucidated. Investigation of
the challenges associated with toxicological analysis of human head hair can lead to more
accurate techniques that, with time, can prove to be reproducible and therefore be reliable
evidence in the courtroom.
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2. BACKGROUND
2.1 Cellular and molecular components of hair fibers
Hair is a fibrous material with an approximately cylindrical morphology comprised of
proteins, lipids, water, melanin, and trace minerals. Melanin accounts for 0.2-1.5% of hair
components, while proteins, mainly keratin, are responsible for 65-95% of hair
composition.17 Hair is comprised of two to three subunits: the cuticle and cortex, and, in
some cases, the medulla. The outermost unit of hair is the cuticle, consisting of dead and
flattened cells that overlay such that they resemble roofing tiles. The edges of these overlaid
scale-like cells point toward the terminus of the hair fiber. The cuticle can be up to 1 µm
thick and serves to protect the cells within the cortex. The cortex contains ortho-, para-,
and meso-cortical cells, which differ in cysteine content.18 Each of these cells contains 5 –
8 macrofibrils, which in turn contain 500 – 800 microfibrils. These microfibrils consist of
type I (acidic) and type II (basic) intermediate filaments (IFs), which are α-keratins that
combine to form heterodimers (Figure 1). Additionally, the cortex consists of keratin
associated proteins, which, along with cytoplasmic and nuclear remnants, serve as the
intermicrofibrillar matrix. Coarser and darker hair fibers have a third subunit, the medulla,
which is comprised of hollow cells, amorphous proteins, and fine filaments.18
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Figure 1: The Morphology of Hair Fibers.18 In the upper right portion of the figure, the
overall structure of hair is demonstrated, denoting the cuticle, cortex, and the medulla. In
the cortex, the presence of a macrofibril within cortical cells, which have a dark outline, is
shown. The overall structure of the macrofibril is indicated in the center of the figure, which
shows a cluster of intermediate filaments surrounded by intermicrofibrillar matrix. The left
portion of the figure shows the structures that make up the intermediate fibril. The αkeratins are named as such because their secondary structure is a right-handed α-helix. Four
α-keratins form a two stranded left-handed coiled-coil which, along with other coiled coils
and matrix, organize into the left-handed protofibril, which is also known as the
intermediate fibril.
Hair fibers form as cells differentiate and organize in the hair follicle, which is an active
mini-organ embedded in the epidermis and dermis of the scalp. The hair shaft that is seen
outside the scalp is comprised of differentiated, dead keratinocytes that originated from
follicular stem cells. Each hair follicle cycles throughout the growth of the hair strand. The
cyclic growth of human head hair has three phases, which are anagen, catagen, and
telogen.1 Anagenesis is the growth phase of hair, when cell division occurs rapidly due to
increased metabolic activity.1 The intermediate phase of hair growth is the catagen phase,
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where the hair is neither growing nor quiescent, but instead undergoing keratinization.1
Blood supply begins to decrease during catagenesis, and is completely halted during
telogenesis. The hair follicle is very short during telogenesis, and is easily displaced by
arising follicular growth.1 At any given time, about 85% of human head hair will be
undergoing anagenesis, 15% will be in the telogenic phase, and only a small proportion of
hair will be in catagenesis.1 Specific processes occur in different regions of the hair follicle
during each phase of hair growth, leading to the differentiation and subsequent
keratinization of stem cells.
There are permanent and non-permanent structures of the hair follicle that are essential
for proper hair growth, as can be seen in Figure 2A. The permanent structures are the
infundibulum, which is the portion of the follicle that extends from the sebaceous gland to
the epidermal surface, and the isthmus, which is the middle part of the hair follicle that is
connected to the basal membrane.2 The non-permanent structures are present in the hair
follicle during anagenesis and include the bulb and the suprabulbular region. The bulb is
the thickened end of the hair follicle that contains rapidly proliferating, undifferentiated
matrix cells, melanocytes, and outer root sheath cells.2 The bulge is comprised of the
dermal papilla (DP), matrix (M), the connective tissue sheath (CTS), the inner root sheath
(IRS), and the outer root sheath (ORS), as seen in Figure 2C. The tip of the DP is a small,
dense cluster of fibroblasts that determines the bulb size, hair shaft diameter and length,
and the duration of anagenesis. The DP is surrounded by the matrix, which contains
differentiated keratinocytes from the DP and melanocytes, which are rapidly proliferating.
The connective tissue sheath is a loose accumulation of collagen and stromal cells that
helps keep the bulb in place upon the basement membrane. The outer root sheath contains
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hair follicle stems cells and is directly fed by the matrix. During anagenesis, the isthmus is
home to the hair bulge, which is a protrusion of the outer root sheath in the inner-most
permanent structure of the follicle, which contains hair follicle stem cells (Figure 2B). The
bulge is where differentiated, keratinized cells become organized into the fibrous structures
in Figure 1.2

Figure 2: Histological longitudinal section of the hair follicle in anagen.2
Keratinization begins at the bulb of the hair root, where alpha helical intercellular
structures, called tonofibrils, form via disulfide bond linkage between the keratin proteins
of adjacent cells that are attached to intramembrane structures, called desmosomes.19 Next,
the cells move away from the dermal papillae toward the hair matrix material, containing
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sulfur-rich proteins that allow for rigid structures to form between cells.19 Finally, the
keratinocytes begin degrading intracellular structures, take on squamous morphology, and
move toward the surface of the epidermal layer to grow out of the follicle.2,19
As the cells in the follicle differentiate, they are pushed out of the follicle and carry
with them granules of the pigment melanin, which is what gives color to human hair and
skin.2 The pigment molecules are produced in melanocytes during the anagen phase, and
become incorporated into the hair structures during keratinization.20 Melanin pigment
granules are spherical aggregates of oligomeric stacks of melanins, which form after the
pigment molecules are synthesized in melanosomes – lysosome-related organelles of the
melanocyte which synthesize melanins from tyrosine.2
Human hair contains two main subclasses of melanin, eumelanin and pheomelanin,
both derived from the biotransformation of tyrosine to dopaquinone and ultimately
eumelanin or pheomelanin (Appendix 1).21 Eumelanin is a brown/black pigment that
contains a high concentration of 5,6-dihydroxyindole-2-carboxylic acid (DHICA).22
Pheomelanin, the reddish-brown hair pigment, undergoes a different biosynthetic process
resulting in a relatively high concentration of 5,6-dihydrocyindole (DHI).21 Additional hair
pigments include oxyeumelanin and oxypheomelanin, which are oxidative products of the
main melanin subtypes.23 Additionally, the different biosynthesis processes involved in
producing eumelanin and pheomelanin result in vastly different indolequinone structures,
as seen in Figure 3.
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Figure 3: Chemical Structures of Melanin Subtypes (adapted from Ito et al., 2008).21 The
eumelanin (A) and pheomelanin (B) subtypes of melanin stack on themselves to produce
the unique pigments seen in human head hair. The ratios in which these melanin building
blocks associate have been suggested to be specific to groups of individuals with the same
biogeographical origin.20
The most significant structural difference between pheomelanin and eumelanin is the
backbone structure. Eumelanin is comprised of indolequinone units, where pheomelanin is
comprised of benzothiazine, benzothiazole, and isoquinolone units. Another important
structural difference between the two types of melanin found in human hair is the position
of the carboxylic acid moieties, as some hypotheses state that these functionalities
contribute to melanin affinity for certain molecules.21 In the structure of eumelanin, the
carboxylic acids are free from steric hindrance and positioned near the secondary amines
of the indolequinone backbone. In contrast, many of the carboxylic acid functions in
pheomelanin are within two bond lengths of a primary amine, since the amine may donate
electron density to stabilize the carboxylic acid in its anionic form, reducing its reactivity.
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2.2 Incorporation mechanisms of drugs of abuse into hair
A consensus has emerged that three incorporation mechanisms contribute to drug levels
in hair.1,2,3,24,25,4–8,10–12 The first involves the systemic circulation of drug-containing blood
to the scalp, where simple diffusion causes drug to move from the blood stream into the
cells in the hair follicle. The second mechanism involves the secretion of compounds of
interest that are dissolved in sweat and sebum onto the scalp, where they can be
subsequently deposited on a growing hair shaft.6 The third mechanism is deposition of drug
onto the surface of hair by exposure to drug-containing aerosols in the surrounding
environment; this is a common route of exposure for smoked or insufflated drugs of abuse.6
While the routes of exposure that lead to the incorporation of drug into hair have been
largely agreed upon, it is still unclear what mechanisms allow for the retention of drugs in
the hair shaft. Several theories regarding the physicochemical mode of interaction between
drug and the hair matrix have been proposed,4,15,16 but none have yet been systematically
studied. Retention of drugs and other xenobiotics in hair may be a result of interactions
between analytes and the components of hair, such as melanin and keratin, through
covalent or ionic binding, van der Waals forces, hydrophobic interactions, or a combination
thereof. The interactions between drugs and hair are likely to be specific to the physical
and chemical properties of the analyte. It has been suggested that basic drugs of abuse may
have covalent interactions with melanin, while acidic drugs may have interactions with
other hair proteins, whether covalent or otherwise.6,13 It is theorized that analytes that are
cationic at physiological pH interact with the anionic carboxylic acids of the melanin
polymer; these electrostatic interactions are further strengthened by van der Waals forces
between aromatic rings in the drug molecules and the aromatic indole rings of melanin.23
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While it has been demonstrated that there are different binding modes of analytes with
different physical and chemical properties, the nature of these associations are not well
understood.
2.3 Hair as forensic evidence
Human head hair has historically been studied as evidence in several contexts. For
example, hair has been examined under the lens of fiber analysis to study the structures of
the cuticle, medulla, and cortex to determine its biological origin, as these structures differ
among mammalian species.26 Additionally, the microscopic evaluation of hair structures
allows for the classification of a hair fiber according to its corporeal location or origin.
Head hair is documented to have an intermediate thickness, 60-80 µm, where pubic and
axillary hair tend to be thicker and coarser than hair on the scalp, and vellus hair is thinner
and less coarse than both scalp and pubic/ axillary hair. 27 Additional measures that can be
used to differentiate the corporeal origin of a hair fiber including the presence/ absence
and thickness of the medulla as it has been observed that pubic and axillary hair is more
medullated than scalp hair and vellus hair.28 Also, the medullary index, or the ratio of the
thicknesses of the medulla as compared to the thickness of the whole strand, has been
shown to be greater in pubic and axillary hair than in scalp hair.28
In addition to species and corporeal provenance, hair specimens can undergo DNA
extraction and subsequent genotyping to trace the sample to a subpopulation or even an
individual. When hair strands are pulled from their source, the follicle may be removed
with the hair strand; since the follicular cells are not yet keratinized, nuclear DNA is still
intact and can be extracted for genotype analysis to attribute the profile to a single
individual.29 At present, the lack of follicular material dictates that a sample will undergo
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mitochondrial DNA analysis, which can provide matrilineal information about the source,
but cannot be used for short tandem repeat (STR) analysis, which the is benchmark
technique for forensic DNA profiling to identify an individual.29 Recent developments
have been reported to indicate that modification of the DNA extraction protocol and STR
primer sets may allow for the identification of a single individual from rootless hair.29
While the provenance of hair is an important use of hair evidence, the focus of many recent
developments in the last two hundred years regard the toxicological information that can
be ascertained from this matrix.
2.4 Hair as a matrix in forensic toxicology
Forensic toxicological analysis for the purposes of protecting human health and
supporting criminal justice activities can be achieved, in part, by means of analysis of
human head hair for detection of abused substances. Forensic drug analysis in any
biological matrix serves to monitor the exposure to a variety of substances, recognize prenatal drug exposure, evaluate abstinence from drug use, and detect exposure to drug
facilitated crime substances. Blood and urine are the most commonly tested biological
matrices for detecting the use or exposure to drugs, and other compounds of interest,
because these matrices are well understood and standard operating procedures exist.1
Alternatives to blood and urine include hair, nail clippings, and oral fluid as biological
matrices.1 These have been explored because their collection involves a less invasive
process than collecting blood or urine from an individual. Additionally, some alternative
matrices, like hair and nail clippings, provide information that blood and urine cannot. The
longer window of detection in hair and nails is a result of growth on the body over time,
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which allows for the detection of substances at different times within the lifetime of the
hair strand or nail via segmental analysis.3
The first report of toxicological data from human hair was by Hoppe in a German
publication describing results of a study of suspected arsenic poisoning.30 The next notable
publication regarding the detection of xenobiotics in hair occurred almost a century later;
Goldblum et al. dosed guinea pigs with barbiturates and subsequently detected these drugs
in the hair of guinea pigs. Drug testing in hair became of particular interest beginning in
the 1980s. The surge began with Baumgartner et al. extracting opiates from hair.31 A year
later, in Germany, Klug published a method to completely degrade the hair matrix with
sodium hydroxide and analyze the codeine and morphine content by immunoassay and
confirmed these results with chromatography, which made this method the first to fulfill
the requirements of methods used in forensic toxicology.30 Next, Valente et al. studied
cocaine and its metabolites under different extraction conditions to determine which
method resulted in the lowest detection limits.32 The methods established to this point had
used alkaline or acidic degradation of the hair matrix to isolate drugs for subsequent
analysis. In 1985, Haley and Hoffman introduced a new method that used acetone and
ultrasonication to extract nicotine and cotinine from hair.33 Subsequently, protocols to
degrade hair via proteolytic enzymes were established using pronase and proteinase K by
Offidani et al. and Harkey et al., respectively.34,35 In the early 1990s, the isolation of drugs
from hair by means of supercritical fluid extraction were reported.36,37
Over time, many of these influential contributors to early hair testing methods
recognized the necessity of establishing quality assurance measures, which led to the
establishment of the only governing body for forensic hair analysis: The SoHT. The SoHT
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has made recommendations on a general scheme of analysis.38 These recommendations
provide an understanding of the steps that are minimally necessary for hair analysis, while
suggesting that laboratories investigate and validate methods to fit within these guidelines.
Prior to forensic toxicological analysis, human head hair requires significant
processing. Pre-treatment steps in the analysis of drugs in hair include decontamination
and segmentation of the hair strand, extraction of the compounds of interest from the hair
matrix, and often, purification of the isolate.6 Different mechanisms to recover drugs from
hair are used with different extraction techniques, e.g., alkaline or enzymatic degradation
of the hair proteins or solvent swelling of the hair structures.

Figure 4: Scheme of Forensic Hair Analysis (adapted from Vogliardi et al.6). The process
of forensic hair analysis begins with the selection of the segment of hair relevant to the
time frame to be investigated. Next, drug superficially associated with the hair surface as
a result of external contamination must be removed through a series of decontamination
washes. The hair sample is then homogenized and exposed to an extraction solution. The
extract is often purified before undergoing qualitative and/or quantitative analysis.
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Over time, a great variety of methods for hair analysis have been developed and
validated, resulting in a practical challenge, as there is little reported work rigorously
comparing the benefits and limitations of using one method over another.6,39–44 The process
begins with the collection of the sample. Hair growth rate has the lowest intraindividual
variation at the posterior vertex of the head, and thus is the ideal location for sample
collection.38 While the SoHT does not make recommendations regarding adequate sample
mass, literature reviews suggest that 10 to 200 mg of hair should be sampled for subsequent
analysis.6,39,45 It is important that the sample orientation be retained such that the proper
segment of hair may be selected for analysis and correlated to an accurate time of exposure.
Once the segment of interest has been cut from the strand, it must undergo a
decontamination process to remove any drug that may be superficially associated with the
surface of the hair as a result of environmental contamination. 3,6,12,38,45–48
The goal of the decontamination process is to remove contaminants from the surface
of the hair fiber without extracting any of the analyte(s) contained within. The SoHT
recommendations dictate that the hair be exposed to an aqueous solvent to remove polar
contaminants and an organic solvent to eliminate nonpolar contaminants.38 It is common
for surfactants, most commonly sodium dodecyl sulfate (SDS), to be added to water for the
aqueous decontamination step.6,45,46 Common organic solvents used for the purpose of
decontamination include protic solvents such as methanol and ethanol and aprotic solvents
such as methylene chloride and acetone.39 Once the sample has been decontaminated, it
must be dried and homogenized. Although the SoHT reports that cutting the hair into
smaller segments or pulverizing the hair are both acceptable methods for the
homogenization of the sample, it has been reported that pulverization results in
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significantly higher recovery of the drug contained within the hair, as smaller particles
increase the surface area of the cortex exposed to the extraction agent.45,46,49,50 Extraction
of analytes from within the hair has been achieved through several means, including
techniques designed to degrade the keratinized sample matrix and those designed to swell
the hair matrix, allowing for passive diffusion of the analytes out of the hair and into the
extraction solution.
The SoHT recommends comparing different extraction techniques when developing a
new protocol to determine the conditions under which analyte degradation is minimized
and recovery is maximized. Some techniques, such as enzymatic, alkaline, and acidic
conditions degrade the keratinized structures of the hair matrix.6,38,39,43,45,46 Alternatively,
application of individual solvents, such as methanol and buffers, or mixtures of solvents
has been used as a gentle and robust method for isolating drugs from the hair matrix by
allowing the imbricate cuticle cells to flare away from the cortex.6,38,39,46,51 Although
alkaline and acidic degradative techniques have been noted to have high extraction
efficiencies for many drugs of abuse, these methods have also been known to cause
hydrolysis of certain analytes, such as cocaine.6,38,39,45 Enzymatic degradation of the keratin
matrix has been reported to have high extraction efficiency under appropriate pH and
temperature conditions to minimize the chemical modification of drugs and their
metabolites. However the presence of enzyme, usually proteinase K, proteinase E, or
pronase, may result in denaturation of antibodies in immunoassays, which are a common
analytical technique for toxicological screening.6,46 Solvent-swelling techniques are useful
for unknown screening to minimize the risk of chemically modifying analytes, but these
typically result in lower extraction efficiency as compared to degradative techniques.6,38,46

19

In addition to the SoHT, the European Workplace Drug Testing Society (EWDTS)
published guidelines for each step of hair testing. The EWDTS and SoHT have similar
guidelines, ultimately stating that each testing lab must validate its own method. Like the
SoHT, the EWDTS dictates that sample collection occur from posterior vertex of the head
and the amount of hair collected should be about the thickness of a pencil (0.5-0.5 cm) in
diameter with root end clearly marked. Decontamination is a necessary step and can be any
combination of aqueous and organic solvents that is validated by the lab. A validated
extraction protocol must be established and may involve drying, pulverizing, cutting into
small pieces, or chemical disintegration of sample. Screening by immunoassay is
recommended to eliminate negative samples; subsequently a validated GC- or LC-MS
method may be used for confirmation of presumptive positives. To improve the signal-tonoise ratio in the MS based methods, clean-up of samples prior to analysis is recommended,
which may include LLE or SPE. The EWDTS has specific guidelines for internal quality
control including low and high control samples at the start and end of a batch analysis. The
low level should be around the accepted cut-off value to indicate a positive result (Table
1). Additionally, it is recommended that each lab participate in annual proficiency tests as
a form of external quality control. 52
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Table 1: Accepted screening and confirmatory cut-off values as reported by the EWDTS.
Cut-off values have been approximately agreed upon among regulatory bodies, such as the
SoHT, EWDTS, and the substance abuse and mental health services administration
(SAMSHA).38,52,53

Once the analytes have been freed from the matrix, it is necessary to eliminate
interferences and isolate analytes. Common clean-up methods for hair extracts include
liquid/liquid extraction (LLE) and solid phase extraction (SPE). Clean-up via LLE exploits
the differential solubility of an analyte in various solvents and is a widely accepted,
reproducible sample preparation technique. Limitations to LLE include emulsion
formation and the necessity of large solvent volumes.46 Alternatively, SPE uses less solvent
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than LLE and serves the combined purpose of separating analytes from matrix components
while simultaneously preconcentrating the sample. However, the high surface area of
typical SPE sorbents can result in low recovery of analytes present in trace amounts and a
strong affinity for the sorbent.46 Once interferences and matrix components have been
removed from the extracts, a number of qualitative and/or quantitative analytical
techniques may be applied to identify and/or quantify the analytes present in the sample.
Common analytical techniques include immunoassay, GC-MS, and LC-MS. The most
recent developments in hair testing have been applied to studying drug use history over the
course of time through mass spectrometric imaging of hair strands from a single individual.
These techniques predominantly employ matrix-assisted laser desorption ionization
(MALDI)-MS and was first reported in 2011 for the analysis of cocaine and its
metabolites.54–56 Analysis of the longitudinal cross-section of a single hair allows for the
imaging of drug species over the length of the hair strand, which then can be correlated to
a specific time in an individual’s drug use history. Other similar methods have been
developed for the detection of methamphetamine, cannabinoids, ketamine, zolpidem, and
tilidine.54,56,65,66,57–64 The selection of the appropriate analytical technique, or combination
of techniques, should be chosen to fit the purpose of the analysis.
2.5 Challenges in hair testing
It is evident that each step in sample preparation and analysis can vary significantly
among laboratories, resulting in a wide variety of approaches to toxicological hair analysis.
In fact, as advances are made in separation sciences and spectroscopy, the analytical
approaches to hair analysis may continue to evolve as well. In terms of the forensic
application of toxicological hair analysis, it is important to recognize that the results of hair
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testing are often presented in court and have real implications in the lives of individuals.
Therefore, it is necessary to establish specific standard practices for the toxicological
analysis of hair such that it is clear what evidence is acceptable for use in the court of law.
In addition to the lack of standardization, other major challenges in forensic hair
analysis are recognized, including a lack of reliable HRM and complex interpretation of
results. A large literature base exists for a variety of analytical techniques and pretreatment
steps in the analysis of head hair for its content of drugs of abuse.1,3,6,7,39,66–68 However, to
date, there are no widely accepted, optimized methods for specific drugs or classes of
drugs. More importantly, there has not been a rigorous statistical comparison of hair
processing techniques with regard to performance.7,49
Additionally, the validated methodologies reported in the literature do not have a
“ground truth” reference material with which the method can be tested for accuracy,
precision, and to fully understand the matrix effects. Currently available HRM are
generally prepared by external “incorporation” of the drug by soaking in a spiked aqueous
solution, which is substantially different than the mechanism by which drugs are
incorporated into the matrix in vivo. Thus, HRM are often inhomogeneous and poorly
representative of real samples. Additionally, with current techniques for the preparation of
reference material, it is difficult to incorporate metabolites of drugs because they are more
polar than parent compounds and less likely to undergo passive diffusion from the
incorporation buffer into the hair matrix. The difficulty incorporating metabolites into hair
is a problem because metabolites are valuable as biomarkers of exposure to a substance.
Unfortunately, at the present time, most xenobiotic substances relevant to forensic case
work are not available as incorporated drug standards in human head hair.
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Finally, the interpretation of hair testing results often requires other information in
addition to the analytical data. The concentration in hair is related to the dose of consumed
drug, but this relationship is not as well understood as it is for blood and urine.14
Interindividual difference in drug metabolism contribute to the complexity in interpreting
results. Also, the distance from the hair root that the sample was acquired is a complicating
factor, as drug concentrations are typically lower farther away from the root, as a result of
UV light exposure and regular hygiene practices like washing. In addition, the polarity of
the drug and the hair color contribute to interindividual differences in detected drug
concentrations. The proportions of hair in the anagen and telogen phases of growth will
contain different concentrations of drug, as incorporation related to consumption only
occurs while the hair follicle is in a growth phase and exposed to drug through systemic
circulation. Finally, cosmetic treatments must be considered during interpretation of hair
testing results, because cuticle damage can be caused by perming, straightening, dyeing
excessive washing, bleaching, and UV exposure. These treatments also can increase hair
porosity, allowing for drug to escape the matrix and increasing the potential for false
negatives.52
One of the greatest challenges and sources of uncertainty in the toxicological analysis
of hair involves decontamination prior to extraction and analysis. Numerous reports exist
evaluating decontamination procedures for removing external drug contamination and
subsequent data interpretation to ensure that measured hair levels only reflect ingested drug
transported via systemic circulation to the hair follicle capillaries.66,67,69–76 To achieve
decontamination, drug superficially associated with the cuticle of the hair must be
removed. External contamination may arise from environmental exposure to smoked or
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powdered drug or via surface contact with drug excreted in sweat or sebum. Important
considerations for hair decontamination include choice of wash solution or solvent, the
quantity of wash solution or solvent used relative to the amount of hair to be
decontaminated, the number of consecutive washes to be performed, and the length of time
hair is agitated in the decontamination wash solutions or solvents.69,70 The SoHT has
endorsed the use of an aqueous wash and an organic wash.38 However, these
recommendations are general, and thus a large number of specific wash procedures have
emerged with a variety of efficacies.
To account for interpretive issues that arise from the external contamination, the
EWDTS has additional confirmatory regulations. To confirm the consumption of COC, at
least two of the following must also be detected: benzoylecgonine, cocaethylene, and
hydroxycocaines. Heroin consumption is confirmed by the presence of 6-acetylmorphine
and morphine in addition to HER. The consumption of methamphetamine must be
confirmed by the presence of AMP in addition to the parent drug. Cannabis consumption
is confirmed by the presence of THC and THC-COOH. The presence of 3,4methylenedioxymethamphetamine

(MDMA)

and

its

metabolite

3,4-

methylenedioxyamphetamine (MDA) are necessary for confirmation of consumption.
Likewise, the confirmation of ketamine requires the presence of its metabolite
norketamine. Finally, the consumption of methadone consumption requires the additional
presence of its metabolite EDDP.52 The FBI has recently adopted similar methods that
require the identification of metabolites in addition to parent drug to qualify a positive
result for cocaine.77 However, interindividual differences in drug metabolism, hair
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structures/texture, and the poor rates of incorporation into hair make quantitation of drugs
and their metabolites unreliable.78
A large literature base serves to provide an analyst with a breadth of techniques that
have been validated for the qualitative and quantitative detection of numerous drugs of
abuse in hair while accounting for some of these challenges. Two approaches to method
development are common threads amongst the many reports; the development of
techniques designed to extract and identify/quantify as many analytes as possible and the
development of a specific technique designed to extract and quantify a particular
compound or class of compounds. The variation in analytical approaches is greatest in
regard to the pre-treatment steps taken to prepare the specimen for quantitative/qualitative
analyses. The present work aims to address the challenges of uncertainty regarding the
mechanism by which drug is held in hair by probing these interactions via spectroscopy;
addressing this challenge helps to account for interindividual differences in hair
structure/color when interpreting results. The present work will also address the variability
in pre-analytical methodology, with a special focus on decontamination, to account for
external contamination and interlaboratory differences.
2.6 Introduction to Statistical Design of Experiments
Statistical Design of Experiment (DoE) is an alternative approach to analyzing the
associations between independent and dependent variables that is commonly used for
product design and process improvement in a multitude of scientific fields. Traditionally,
the approach to determining the effect of each independent variable on the dependent
variable is to vary the levels “One Factor at a Time” (OFAT) to assess their individual
effects on the response, or dependent variable. Subsequently, another variable can be tested
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at different levels while holding the first variable and the others at constant values. The
OFAT method of testing requires an abundance of time and materials, making it inefficient
and often infeasible. Alternatively, DoE allows for the variation of all parameters
simultaneously in order to observe the associations between changes in the dependent
variable and the changes in each of the factors and combinations of factors (i.e.,
“interaction effects”).79,80
The theory behind DoE is derived from the statistical approach to hypothesis testing.
The goal is to determine if a statement about a population parameter is true based on a
random sample. In general, hypothesis testing, and thus DoE, includes testing a null
hypothesis against an alternative hypothesis, with the intent of minimizing the probability
of rejecting the null hypothesis when it is true (type I error). Minimizing type I error
reduces the probability of false positives. Therefore, a significance level must be chosen
such that the probability of type I error is minimized. Once this is done, an experiment can
be conducted on a representative population of samples, and statistical analysis (such as a
Student’s t-test) can be conducted to compare the experimental parameter to the total
population parameter. If there is no significant difference between these parameters at the
chosen significance level then there is insufficient evidence to reject the null hypothesis.
When comparing more than one parameter, a more sophisticated statistical analysis
must be used, such as analysis of variance (ANOVA). The ANOVA model, in its simplest
form, can be seen in Equation 1, where Yij is the continuous, numeric response of the
dependent variable for the jth observation of treatment ith, µ is the overall population mean
of the response, τi is the deviation of the group mean from the overall mean, and εij is the
deviation caused by random error.79
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Equation 1
The purpose of ANOVA is to identify if there is a source of variance in a data set associated
with different treatments applied to groups of samples (τ), rather than random error (ε). As
seen in Figure 5, by plotting the variation of samples within treatment groups versus the
overall population mean, the magnitude and direction of the variance resulting from
treatment can be determined.79 Simply stated, ANOVA separates the variance in a data set
associated with a treatment from the variance associated with random error. When the
random error is “purified” in this way, the power of the analysis is increased because the F
statistic becomes more accurate when sources of known error are teased out of the random
error.

Figure 5: Visual demonstration of ANOVA. ANOVA is capable of determining whether
group mean(s) are significantly different from the overall population mean. Subsequent,
post-hoc analysis allows for the description of the direction and magnitude of that
difference.
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An ANOVA F-test is subsequently used to determine if the mean of the treatment groups
are significantly different than the population mean (i.e., the variance between the groups
is larger than the variance within groups).79 If the variation resulting from treatment is
significant at a chosen significance level, then there is insufficient evidence to reject the
null hypothesis that the treatment does not affect the outcome, on average.
The ANOVA F-test is only capable of determining if the treatment group mean is
significantly different than the overall population mean; it is not capable of telling which
groups are significantly different, or by how much. Instead, post-hoc analysis is applied
for this purpose. When comparing the effect of several treatments, type I error is inflated
by multiple-comparisons (i.e., multiple t-tests). Post-hoc testing adjusts the significance
level to account for a family-wise type I error, thus minimizing the potential for overall
type I error. Tukey’s HSD is the best method for pair-wise comparisons while adjusting
the overall error rate.79
There are a variety of DoE approaches, each with its own purpose. Factorial designs,
which are used to consider two or more treatment factors, especially when the interactions
among these factors are of interest, are especially useful in the beginning stages of
experimental work involving many factors of interest. The purpose of a factorial design is
to screen all possible combinations of the levels of the factors of interest, which are studied
in each complete trial of the experiment while minimizing the number of runs. Factorial
design types are defined by the number of levels of each factor under study and the number
of main factors of interest, i.e., independent variables. Nuisance factors are any variables
that are difficult to control and result in an inability to perform all the runs of an experiment
under homogeneous conditions. In some cases, there are two or more nuisance factors; the
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result is such that two or more “blocking factors” must be used. Randomization of the run
order is necessary to eliminate systematic error. Sometimes, it is not practical or feasible
to completely randomize all the runs necessary to complete a trial of the experiment as a
result of nuisance factors, necessitating the use of blocks within the design. In this case, it
is necessary to confound the design; confounding a design involves arranging the complete
design into blocks that are smaller than the total number of treatment groups. The
consequence of confounding a design is information loss, usually from higher-order effects
as these effects become indistinguishable from the those of the blocking factors.79 These
types of designs are referred to as fractional factorial designs. Specific examples of
factorial and fractional factorial designs are given in Chapters 4 and 5 as they relate to the
research herein.
Applications of DoE include optimization of cell culture conditions and processes to
increase the yield of useful cell products like biopharmaceuticals, optimization of synthetic
conditions to result in high yield and desirable products, and the optimization of HPLC
methods for the separation of analytes.81–86 For example, Debrus et al. used a full factorial
design to optimize an HPLC method for the analysis of pharmaceuticals considering the
mobile phase pH and gradient times as the main factors. The HPLC method was developed
using a C18 reverse-phase column, which has a pH tolerance from 2.6 to 10; five buffers
were prepared with different pH values within this range for the DoE runs. Linear gradients
from 95% aqueous to 5% aqueous were employed; three levels, or gradient times, ranging
from 10 min to 30 min were used in the DoE runs. The dependent variable, or response
factor, was the resolution of the peaks in the resultant spectra. The result of these
experiments determined that the optimal resolution between the chromatographic peaks
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was obtained using a buffer at pH 3.1 with a gradient time of 30 min.84 Similarly, De Backer
et al. used a full factorial design to optimize HPLC chromatographic conditions with the
aim of optimizing the resolution of the chromatographic peaks resulting from the reversephase separation of a variety of natural cannabinoids. The factors under study were the
percent of organic mobile phase at the start of the gradient, the gradient time, and the pH
of the aqueous mobile phase. The results indicated that the optimal resolution between the
chromatographic peaks of the cannabinoids occurred when the gradient started with 68%
organic mobile phase, followed by a 30 min linear gradient with an aqueous buffer at pH
5.2 .85
There are two types of multivariate approaches to analytical method optimization; these
are screening designs and optimization designs. Screening designs are typically used as a
first step in the DoE process to determine which, if any, of the parameters of interest have
significant impact on the response. Subsequently, these parameters may be optimized. The
designs commonly used for screening purposes are the Plackett-Burmann design and 2k
factorial designs.81,84 Plackett-Burmann designs are limited in that they are not able to
determine the significance of high-level interaction factors, where 2k- factorial designs
can.50 Once the significant factors have been identified, they can be optimized through a
full factorial, central composite, or D-optimal design.84 The full factorial design includes
all combinations of all factors as design points.79 The central composite design places
experiments around the design center in the design space, which indicate the optimum
conditions.81 D-optimal designs are useful when the design space is constrained and the
covariance of parameters is low.84,87
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2.7 Selection of analytes
Analytes of interest, specifically AMP, COC, MOR, and THC, were identified from
commonly abused substances and from substances for which cut-off values have been
established by the SoHT.38 Diazepam was chosen as an analyte because it is a widely used
prescription drug that is also used in drug facilitated crimes (DFC), which is a common use
of toxicological data derived from hair samples.43 These analytes have shown moderate to
high abuse potential, which is defined in by studies in which individuals are given
controlled doses of the drug and report the positive and negative effects they experience
and their likelihood of using again based on those experiences.88–92 Forensic hair analysis
may be performed looking for DFC cases, as was previously noted specifically for DZP,
child custody cases, driver’s license reissuing, and workplace drug testing.47,52,57,93
The physical and chemical properties of substances, including lipophilicity, acid-base
properties, chemical structure, and affinity to melanin, have been cited to influence their
incorporation and retention in hair.1,3,7,25,47 Therefore, the properties of select drugs of
abuse were considered when choosing the analytes for this work. Lipophilicity can be
understood through the logP value of the substance, which is a partition coefficient that
allows for the understanding of the neutral molecule’s affinity for octanol and water, two
immiscible phases. A logP value greater than 1 indicates that the substance preferentially
separates into the hydrophobic phase, and thus is increasingly more lipophilic as the logP
value increases.94 To understand the polarity of the substance, the topological polar surface
area (TPSA) can be explored. A TPSA of ~90 Å2 indicates a relatively polar structure that
is unlikely to cross the blood brain barrier, while a TPSA >140 Å2 indicates a substance
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that is very polar and will not cross the blood brain barrier.7 These properties for the
analytes in this work are summarized in Table 1.
Amphetamine (AMP) is a basic drug with an unsubstituted phenyl ring, a two-carbon
side chain between the phenyl ring, and a primary amino group. It is the prototypical
structure, seen in Table 1, of the phenethylamine class of drugs. The logP of AMP is 1.8,
which indicates that it is relatively lipophilic in its neutral form. The pKa of AMP is 9.9,
indicating that it is a basic drug that will be protonated at physiological pH. The TPSA of
amphetamine is 24 Å2, indicating that the drug is somewhat polar, but not so much as to
prevent passage across the blood brain barrier. Amphetamine is sparingly soluble in water,
and aqueous solutions are alkaline to litmus paper. The chemical structure of AMP does
not include an acidic function or an alkyl or benzyl functional group on the nitrogen.95
Cocaine (COC) is an amphoteric alkaloid consisting of a benzene ring and a
cycloheptane ring connected via ester linkage. The cycloheptane ring has a nitrogen bridge
between position 1 and position 5 and esters on positions 2 and 3. The logP of COC is 2.3,
indicating that it is a lipophilic substance in its neutral form. The pKa of the tertiary amine
is 8.6. The TPSA is 56 Å2, suggesting that the structure is somewhat polar, but still capable
of crossing the blood brain barrier. Cocaine is sparingly soluble in water, and aqueous
solutions are alkaline to litmus paper. The structure of COC does not include an acidic
function, and it does include N-alkyl groups, as the amine acts as a bridge between carbon
atoms in a cycloheptane ring.95
Morphine (MOR) is a pentacyclic opiate alkaloid with an oxygen bridge between
position 4 and position 5, phenolic groups at position 3 and position 6, and a tertiary amine
between position 9 and position 16. The logP of MOR is 0.8, suggesting that it is
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hydrophilic in its neutral form. The pKa of the tertiary amine is 8.02 and the pKa of the
hydroxyl group on position 3 is 9.85. The TPSA is 53 Å2, suggesting that the structure is
somewhat polar, but still capable of crossing the blood brain barrier. The pH of a saturated
solution of MOR in water is 8.5, indicating its alkalinity in aqueous solution. The structure
includes an acidic hydroxyl group and alkyl substitution of the amino group.95
Δ9-Tetrahydrocannibinol (THC) is a tricyclic cannabinoid with a hydroxyl group on
position 1, a five-carbon alkyl chain on position 3, two methyl substitutions at position 6,
and a methyl group at position 9. The logP of THCis 7, which indicates that it is very
lipophilic. The pKa of the hydroxyl group is 10.6. The structure includes an acidic function
(hydroxyl); however it is largely a neutral, hydrophobic structure. The TPSA is 30 Å2,
indicating that the structure is relatively non-polar. The structure does not include an amino
group.95
Diazepam (DZP) is a benzodiazepine with a tertiary amine at position 1 and an imine
at position 4, a ketone at position 2, and a chlorine at position 7. The logP of DZP is 2.9,
indicating that in its neutral state it is very lipophilic. The pKa is 3.4. The TPSA of DZP is
33 Å2, indicating that is it relatively non-polar. The structure of DZP does not include acidic
hydrogen atoms, but it does include alkyl substitution of the amine.95
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Table 2: Structures and physiochemical properties of the drugs of abuse incorporated into
blank hair.
Drug

Structure

pKa

Cocaine

NH2

Amphetamine

Morphine

Δ9-Tetrahydrocannabinol

Diazepam
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TPSA
(Å2)

Log P

8.6

56

2.3

9.9

24

1.8

9.9
(-OH);
8.0
(amine)

53

0.9

10.6

30

7.0

3.4

33

2.8

3. PREPARATION OF INCORPORATED/ENTRAPPED, SINGLE ANALYTE HRM
3.1 Introduction
Acquisition or preparation of HRM is essential for the development and validation of
methodologies used in forensic hair analysis. There are generally three types of HRM:
incorporated/entrapped HRM, externally contaminated HRM, and authentic HRM.
Incorporated/entrapped HRM is prepared by exploiting the hydroscopic nature of hair to
swell the cortex of the hair structure such that the scales of the cuticle are forced to move
away from the one another, allowing the cortex to become exposed to the surrounding
solution. Subsequently, any drug dissolved in the solution may enter the hair structure by
means of passive diffusion.96 Externally contaminated HRM, which is used primarily for
study of hair decontamination methods, has been prepared in a number of ways, but in
general involves the application of drug to the surface of the hair structure either by rubbing
the neat solid onto the hair or spraying a solution of the drug onto the hair.67,69,76Authentic
HRM is prepared by collecting specimen from individuals who self-reported as regular
users of specific analytes and quantitating the self-reported substances in these specimen.
At present, HRM containing selected xenobiotic substances are only available on a limited
basis. Unfortunately, most xenobiotic substances relevant to forensic case work are not
available as incorporated or authentic drug standards in human head hair. When HRM for
a particular analyte is available for purchase, it is typically prepared using the same scheme
as in this study, using an analyte-containing solvent mixture.
As previously discussed, a consensus has emerged that three primary incorporation
mechanisms contribute to drug levels in hair.1,3,5,6,8,17,47,97–99 Exposure can be a result of
drug-containing blood flow to the hair follicle, deposition of drug dissolved in sweat/sebum
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onto the hair shaft, and exposure to drugs from drug-containing aerosols in the
environment.47 This knowledge is exploited to prepare HRM, where reference materials
generally are prepared by soaking human head hair in xenobiotic-containing aqueous
solution. The general concept of incorporation by exposure to a drug-containing solution
is demonstrated in Figure 6. Mechanistically, this method most closely resembles the
process of drug becoming incorporated in head hair after exposure to drug-containing
sweat.

Figure 6: General Schematic of Incorporation Technique Employed to Prepare HRM. A:
Drug-free hair is obtained. B: Drug-free hair is soaked in an aqueous solvent, causing the
cuticle to swell and partially expose the cortex of the hair shaft. C (longitudinal crosssection): After spiking the aqueous solvent with the drug, simple diffusion allows drug to
move between the swollen cuticle scales into the cortex of the hair. D: Aqueous solvent is
evaporated, allowing the cuticle to smooth back over the cortex. This results in the
incorporation of drug into the cortex of the hair and/or entrapment of the drug between
cuticle scales.
The present work employed this incorporation technique to prepare HRM for
amphetamine, cocaine, morphine, diazepam, and Δ9-tetrahydrocannabinol. It was
hypothesized that the aqueous buffer system would need to be adjusted specifically for
each substance to maximize the diffusion of drug into hair, as this process is predicted to
have some dependence on the analyte’s pKa, lipophilicity, acid-base properties, chemical
structure, and affinity to melanin.1,3,7,25,47 More polar compounds are less likely to be
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incorporated into hair because it is more difficult for these substances to cross cell
membranes. Basic drugs are favorably incorporated into hair as a result of the pH gradient
between blood (~7.4) and the cells in the hair follicle (~4.5-5.5).3,4,7,20 Additionally,
protonated amino groups of basic drugs can interact with the free carboxyl groups on
melanin.5,20 Additional factors noted to promote the incorporation of substances into hair
are the presence of a nitrogen atom to facilitate association with melanin, the absence of
an acidic function, and the presence of a long N-alkyl chain and/or N-substituted benzene
ring.1,7
3.2 Materials and Methods
3.2.1

Chemicals and Solvents

Solvents and chemicals used for the preparation of mobile phases and sample
preparation for LC-MS analysis (water, methanol, 2-propanol, dichloromethane, formic
acid, ammonium formate) were of HPLC-grade and obtained from Fisher Scientific
(Hampton, NH, USA).
Stock solutions of AMP, AMP-D11 DZP, HER, COC, DZP-D5, MOR-D3, and COCD3 were obtained at 1.0 mg/mL in methanol from Cayman Chemical (Ann Arbor, MI,
USA). Solutions of Δ9-THC and Δ9-THC-D3 in acetonitrile, with concentrations of 10.0
and 1.0 mg/mL, respectively, were purchased from Cayman Chemical. These stock
solutions were used in the preparation of the wet chemistry-based incorporated HRM and
calibration curves. 1,4-Dithiothreitol (DTT) was purchased from Sigma-Aldrich (St. Louis,
MO, USA), and Proteinase-K was obtained from Invitrogen (Carlsbad, CA, USA). Three
kDa molecular weight cut off PTFE spin filters were obtained from MilliporeSigma
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(Burlington, MA, USA). Single donor, unprocessed, natural black color human hair (~300
g) was obtained from a commercial source.
3.2.2

HRM Production by Wet Chemistry-Based Incorporation

Samples of human head hair (800 mg) were soaked in 1X PBS, pH 6, spiked with drug
stock solution at 1,500 pg/mg hair. Samples were incubated at 37°C while on an orbital
shaker in a temperature-controlled oven. Aliquots of hair and spiked PBS solution were
taken at 0, 24, 48, 72, 96, and 120 h to monitor drug incorporation. The hair aliquots were
washed three times with 1X PBS, pH 6, and once with 2-propanol for 1 min with agitation.
Six aliquots of 30 mg of washed hair were then pulverized using a Mini-BeadBeater 24
ball mill (Biospec; Bartlesville, OK, USA) at 3200 rpm for 30 s. Subsequently, three
aliquots of pulverized hair was subjected to solvent extraction, followed by centrifugation,
SPE, and LC-MS. The remaining three aliquots of hair were subjected to enzymatic
extraction, followed by centrifugation, SPE, and LC-MS. Additionally, the spiked buffer
solutions, extracted samples, and wash solutions were analyzed for their drug content by
LC-MS. The total mass of hair was washed after incorporation with 3 volumes (150 mL
each) of 1X PBS followed by 1 volume of 2-propanol for 1 min each. The hair was dried
at 40°C for 24 h in an oven, and then stored in aluminum foil at room temperature. This
method was modified from Ropero-Miller, et al.96
Initially, small-scale incorporations were performed in triplicate at the pKa of the
analyte, at two pH units above the pKa, and at two pH units below the pKa. The pH at which
the incorporation of the analyte was highest was used for the large-scale, preparative
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incorporations, which were later used in the pre-treatment DoE studies. These methods can
be understood in the schemes in Figure 7.

Figure 7: Depiction of small-scale and large-scale incorporation schemes.
3.2.3

Isolation of Drugs from Human Head Hair

Two extraction techniques were compared. Enzymatic degradation of the hair matrix
was conducted by first incubating 30 mg of hair with 12 mg/mL DTT for 2 h at 37°C, then
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with 2 mg/mL proteinase K for 12 h.100 Solvent swelling of the hair matrix to allow for the
extraction of drug held within the cortex was achieved by incubation of the hair in a mixture
of methanol, acetonitrile, and 2 mM ammonium formate (25:25:50 v/v) at 37°C.51 Samples
were incubated for 24 h and subsequently centrifuged at 10,000 x g to separate the hair
particulates from the solution containing recovered drug. The supernatants from the
enzymatically degraded samples were then centrifuged at 10,000 x g using a 3 kDa
molecular weight cut-off PTFE spin filter. The eluent solution was subjected to SPE
cleanup and LC-MS analysis.
3.2.4

Solid Phase Extraction

For cleanup of hair extracts, Agilent Technologies (Santa Clara, CA, USA) Bond Elut
Certify mixed mode cartridges were used following a method characterized for hair
samples by Miller et al.101 The cartridges were installed on an SPE manifold with clean
manifold liners. Under 3 mm Hg vacuum, the cartridges were conditioned with two 1 mL
volumes of methanol and then two 1 mL volumes of 1X phosphate buffered saline, pH 6
(1X PBS). Next, the samples were spiked with a deuterated surrogate of the drug of interest,
to serve as an internal standard. The samples were loaded to the cartridges at 1 mL/min
under 3 mm Hg vacuum. The cartridges were then washed to eliminate matrix components
with 1 mL of deionized water followed by 0.5 mL of 0.01 M acetic acid. The cartridges
were then dried under vacuum for 10 min. A third wash was then conducted with 50 µL of
methanol, and the cartridges were dried again for 2 min. Elution of the compounds of
interest was conducted by addition of 0.75 mL of ethyl acetate with 2% ammonium
hydroxide at 1 mL/min and subsequently with 0.75 mL of a mixture of dichloromethane,
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2-propanol, and 2% aqueous ammonium hydroxide (78:20:2 v/v). The eluted samples were
evaporated to dryness in a vacufuge for 1.5 h at 45°C. Finally, the samples were
reconstituted in 500 µL of methanol for LC-MS analysis.
3.2.5

HPLC-MS Analysis

For drug analysis, 2 µL of each isolate was injected onto a reversed-phase liquid
chromatography column and subsequently analyzed by QqQ. The compounds were
separated using an Agilent Technologies 1.8 µm Zorbax Eclipse Plus C18 rapid resolution
HD column (2.1 x 150 mm; 1.8 µm). The aqueous mobile phase used was water with 0.1%
formic acid and 5 mM ammonium formate. The organic phase was MeOH with 0.1%
formic acid. The separation was conducted using a gradient solvent system as follows: at
0 min the mobile phase was a 95% aqueous and 5% organic mixture, from 0 to 5 min the
gradient adjusted to 100% organic mobile phase, from 5 to 8 min the gradient was held at
100% organic to flush the column. The mobile phase flow rate was 0.3 mL/min.
An LC-QqQ multiple reaction monitoring (MRM) method was used for the
identification of analytes using an Agilent 6470 triple quadrupole mass spectrometer
operated in positive ESI mode. The cycle time was 500 ms. The cell accelerator voltage
was 4 V. The drying gas (N2) was heated at 350°C, and had a flow rate of 12 L/min. The
sheath gas was also heated to 350°C and had a flow rate of 11 mL/min. The peaks were
confirmed by MRM transitions corresponding to the integrated chromatographic peak. The
MRM peaks were specified in the LC-MS method using the two most abundant transitions,
one as a quantifier and the other as a qualifier. These transitions were identified by
Agilent’s MassHunter Optimizer program and are listed in Table 3. The data were acquired
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in Agilent MassHunter Qualitative software v.8. The spectral peak areas were integrated,
and the data files were then imported into the MassHunter Quantitative software v. 7 for
quantitation of the analytes.
Table 3: MRM transitions selected for LC -MS method.
Compound

AMP
AMP-D11
Cocaine
Cocaine-D3
Diazepam
Diazepam-D5
Morphine
Morphine-D3
Δ9-THC
Δ9-THC-D3

MRM Transition(s)
Precursor Product
Ion (m/z) Ion (m/z)
119
136
91
130
147
98
182
304
82
185
307
85
222
285
193
198
290
154
201
286
155
126
289
61
193
315
123
196
318
93

A calibration curve was generated using drug standards with a 1 mg/mL concentration
and the corresponding deuterated compound. The drug standards were diluted in MeOH to
a final volume of 500 µL to generate calibration solutions with 1, 5, 15, 35, 75, 150, 200,
and 250 ng/mL concentrations. Each calibrator also included 100 ng/mL of deuterated
internal standard.
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3.3 Results
3.3.1

Small-Scale Incorporations

The results of the small-scale incorporations can be seen in Table 4. The highest
recoveries for COC and THC were observed at the pKa of the analytes, which are 8.6 and
10.6, respectively. There was no observable difference in the incorporation of MOR when
the buffer was adjusted to different pH. Large-scale incorporations were performed at the
pKa of COC, MOR, and THC in accordance with these results. Small-scale incorporations
were not performed for AMP and DZP.
Table 4: Average recovered drug from small-scale incorporated/entrapped HRM under
various buffer conditions.
Drug

Incorporation
Condition

pH 6.6
pH 8.6
Cocaine
pH 11.6
pH 6.2
pH 8.2
Morphine
pH 11.2
pH 8.6
pH 10.6
pH 12.6
Δ9-THC
90% 1X PBS,
pH 8: 10%
MeOH
nd - none detected.
3.3.2

Average amount of
Extracted Drug
(pg/mg)
nd
40±24
nd
2±0
2±0
2±0
24±10
30±5
10±8
15±9

Large-Scale Incorporations

The various analytes were found to incorporate into natural black color human hair to
different extents (Table 5). For AMP, 91% of the drug spiked into the buffer was later
extracted and detected after the incorporation was completed. The highest amount of
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incorporated and recovered drug, among the analytes studied, was detected for AMP with
1,369 ± 414 pg/mg of drug detected. The next highest extent of incorporation and recovery
of drug through extraction was observed for DZP; 315 ± 51 pg/mg of drug was extracted
from hair after incorporation, which accounted for 21% of the original 1,500 pg/mg spiked
into the incorporation buffer. THC, MOR and COC had low levels of incorporation and
subsequent extraction. The amount of THC extracted from incorporated hair was 118 ± 29
pg/mg, which accounted for only 8% of the drug originally spiked into solution for
incorporation. The extent of incorporation of MOR and COC was <5%.
Table 5: Average recovered drug from large-scale incorporation/entrapment of drugs of
abuse in HRM.
Drug
Amphetamine
Diazepam
Δ9-THC
Morphine
Cocaine

Spiked
(pg/mg)
1,500

Extracted
(pg/mg)
1,369 ± 414
315 ± 51
118 ± 29
78 ± 34
57 ± 21

% Incorporated
91
21
8
5
4

3.4 Discussion
The amount of drug that was incorporated into the HRM was some portion of a known
concentration that was intentionally added to the buffer solution used to swell the cuticle
of the hair. The drug under study was then able to enter the hair strand by passive diffusion.
Subsequently, the amount of drug that became incorporated was analyzed, and the material
served as a reference for authentic specimen in subsequent experiments.
The ability of some compounds to associate more readily with hair has been
hypothesized to be influenced by a number of factors, including the lipophilicity, pKa,
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structure, size, protein binding capacity, and melanin affinity, with each drug having
unique mechanisms by which it is held in hair.47 Incorporation of substances into hair
following either systemic or direct external exposure may be due to covalent or ionic
binding between hair components and the compounds of interest, van der Waals forces,
hydrophobic interactions, or a combination thereof. It has been demonstrated in numerous
studies that drugs can associate with melanin.2,4,103,104,11,18,20–22,47,99,102 The nature of these
associations is not well understood. However, it has been suggested that basic, lipophilic
drugs may have a greater affinity for binding/interacting with melanin.3
The physical and chemical properties of the drugs under study in the present research
are different, which likely contributes to the differences in their extent of incorporation.
Amphetamine had the highest levels of incorporation by swelling the cuticle of the hair
and allowing for passive diffusion of the drug from the solution into the hair. Amphetamine
is the only drug included in this study that has a primary amine, which may allow for ionic,
covalent, or polar interactions between AMP and the carboxylic acid moieties of
eumelanin, a hypothesis that will be discussed more fully in Chapter 6. The next most
extensive incorporation was observed for DZP. The structure of DZP is such that there is
a benzene ring on a rotatable bond, which may allow the drug to more freely participate in
π-π interactions with the aromatic portions of melanins. Finally, THC was observed to
incorporate at lower, but still detectable amounts. The low incorporation of THC may be a
result of the high lipophilicity of the drug, which would allow for the association with
lipophilic regions in keratin and keratin-associated proteins and/or the 18-methyl
eicosanoic acid in the cell membrane complex of the cuticle of the hair. Cocaine and MOR
did not incorporate extensively into hair by means of passive diffusion. Morphine is a
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relatively large, multi-cyclic drug with ionizable hydroxyl moieties and a tertiary amine.
The low incorporation of MOR may be a result of its large, relatively polar structure.
Cocaine is an amphoteric drug with an ionizable tertiary amine. The TPSA of COC is
relatively high, indicating that it is somewhat polar, which like MOR, may be the cause of
its low incorporation into hair. Additionally, variation in the incorporation of different
analytes under different pH conditions may be a result of differences in the charge state of
the drug and/or components of hair.
Ropero-Miller et al. were able to incorporate AMP, COC, MOR and THC using the
same method employed in the present work. While the amount of AMP incorporated in the
present work was comparable to concentrations observed by Ropero-Miller et al. with the
same, relatively high, variability, COC, THC, and MOR were incorporated at much lower
concentrations in the present work than previously reported.96 The high levels of variability
were attributed to using whole strands of hair, which limits the surface area of the cortex,
where drug is believed to interact with hair components for their subsequent retention in
the material, exposed to the incorporation buffer.96 These authors were also able to
incorporate MOR in multi-analyte HRM; in the present study, MOR was incorporated at
low amounts with high variability.
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These differences may be a result of differences in

diffusion rates of MOR into hair when multiple analytes are in solution, and in the RoperMiller et al. method, when compared to a single analyte solution, as was used in this work.
To date, incorporates/entrapped HRM containing DZP has not been reported. RoperoMiller

et

al.

also

reported

that

high

variability

in

concentration

incorporated/entrapped HRM lead to analytical uncertainty.96 While
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in

the

incorporated/entrapped HRM is still available, it has become less available as authentic
HRM use for method development and validation has become favorable.
Using incorporated HRM for DoE studies has both benefits and limitations. The
greatest advantage of incorporated HRM over other types of reference material, such as
authentic user hair, is that it can be prepared to contain either single analytes or multiple
drugs with adequate concentrations for subsequent extraction and quantitation, as was
demonstrated by Ropero-Miller et al.96 The concentration of AMP incorporated in the
present study was consistent with that reported by Ropero-Miller et al. using the same
incorporation method. However, incorporation of COC, MOR, and THC was significantly
less than reported previously. For DZP, previous reports of reference concentrations
following incorporation are unavailable.96 A major limitation of using incorporated HRM
is that the exact mechanism by which drugs are held within the hair matrix is not yet fully
understood; therefore drug incorporated into hair by means of diffusion from a buffer
solution may not perfectly represent drug incorporated by means of blood flow to the hair
follicle, as in authentic specimens.
Finally, it is important to consider the applicability of these reference materials, as they
do not necessarily represent authentic specimens. Amphetamine and COC are two of the
most widely studied drugs of abuse in hair, and it is well known that both incorporate into
hair readily after systemic use of the drug.90,92 Here it was seen that AMP incorporated
extensively by means of swelling the cuticle of the hair away from the cortex with a mixture
of aqueous and organic solvents, but COC did not incorporate well by these means.
Nevertheless, these incorporated HRM did allow for a proof of concept study of the pre-
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treatment and extraction parameters in a controlled manner using the DoE approach
outlined in Chapter 4.
3.5 Conclusions
Incorporated/entrapped HRM was successfully prepared for use in subsequent
experiments for AMP, THC, and DZP. The extent of incorporation of MOR and COC was
too low to for repeatable experimental results, and thus not carried into the DoE studies.
The low incorporation rates of MOR and COC is likely due to their relatively high polarity
as compared to the other analytes in this study.
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4. SYSTEMATIC COMAPRISON OF HAIR DECONTAMINATION PARAMETERS
VIA 24 FRACTIONAL FACTORIAL BLOCK DESIGN
4.1 Introduction
One of the greatest challenges and sources of uncertainty in the toxicological analysis
of hair involves decontamination prior to extraction and analysis. The purpose of
decontamination is to remove oils, lipids, and cosmetic products and to eliminate any
analyte that may be superficially associated with the surface of the hair as a result of contact
with contaminated surfaces or drug vapors and residues that may exist in the environment
of the individual being sampled.69 Important considerations for the decontamination of hair
samples include the choice of solvent/solution used to wash the hair, the volume of that
solvent/solution used in relation to the amount of hair being decontaminated, and the length
of exposure of the hair to these solvents/solutions.69,70
Removal of external contamination from hair is not necessarily a simple process. For
example, a recent study by Cuypers et al. reported that aqueous wash procedures, rather
than removing surface contaminated drug, can actually move it deeper into the hair
matrix.66 A decontamination procedure for a lipophilic drug, such as THC, may be
ineffective for polar drugs such as cocaine.105 The SoHT has endorsed the use of an aqueous
wash step followed by an organic wash.38 However, these recommendations are general,
and thus a large number of analyte-specific wash procedures have emerged with a variety
of effectiveness.35,74,76,101,105–108
Studies have been conducted to compare some of the more commonly employed
techniques for decontamination as complete protocols or individual variables involved in
the wash protocol. For example, Stout et al. compared decontamination protocols
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originally reported by Cairnes et al. and Romano et al. to study their efficacy for removing
COC from the surface of hair, finding that neither method was sufficient for removing all
of the surface contamination, a result consistent with the findings of the original authors of
each technique.69,72,74 Ropero-Miller et al. and Morris-Kukoski et al. also observed that the
Cairnes et al. decontamination protocol was insufficient for removing COC from the
surface of hair.106,109 Duvivier et al. compared complete protocols for the decontamination
of THC, finding that a multi-step wash with a combination of methanol and SDS was most
effective.76 Mantineiks et al. compared the efficacy of several solvents in regard to
removing COC and methamphetamine contamination, finding again that none resulted in
the complete removal of the drug.75
Although, as described above, reports do exist that compare selected hair
decontamination procedures for specific drugs, to date there has been no comprehensive,
statistically rigorous, side-by-side evaluation of decontamination approaches for multiple
classes of drugs. Considering the lack of systematic comparative analysis of
decontamination protocols for a wider set of commonly abused drugs, the present study
employed a DoE approach to assess a limited set of variables in the decontamination
process for AMP, DZP, THC, COC, and HER. Instead of including MOR in this study,
HER was chosen as it is a commonly smoked drug, where MOR is more likely to be
injected intravenously;95 as discussed in Chapter 1, smoked drugs pose a greater risk for
external contamination than drugs that are introduced via different routes of exposure.
These drugs were chosen because they pose high potential for external contamination.
Powders can be aerosolized and deposited on hair; HER, COC, DZP, and AMP are often
purchased by users as powders or pulverized into a powder by users before use.48,95 Another
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means by which drugs are aerosolized and subsequently may cause external contamination
is through smoking, as is a common route of administration of THC.95
As an example of DoE, a 24 fractional factorial design allows for the determination of
the effects of four factors, each with two levels (high and low), and the combinations of
these factors on the dependent variable. The factors are denoted with upper-case letters (A,
B, C, D, etc.). Each factor has a high and a low level. The 2k notation refers to the number
of combinations of factor levels, with k being the number of factors under study. These
combinations of levels are called design points. Each design point is denoted with lower
case letters, such that if the letter is listed, the factor is held at the high level in the design
point. Since none of the columns of the main factors (A, B, C, D, etc.) in the design are
exactly the same nor opposite, the columns are said to be linearly independent, allowing
for the ANOVA to be solved as a linear model.
Often, there are factors in an experiment that are known to have a predictable effect on
the dependent variable, but these factors are not of interest, therefore they are called
nuisance factors (also known as blocking factors). When only one replicate of each design
point is available, it is impossible to observe all interactions of factors. By using nuisance
factors to block the design points, the unobservable interactions can be controlled. The
design intentionally allows the block to be completely the same or opposite of only one
higher order interaction (i.e., 2, 3, 4, etc.-factor interactions); the two are said to be
completely confounded, meaning that ANOVA will not be able to separate the variance in
the data set resulting from the block from the variance that is resulting from the confounded
interaction. Thus, we cannot observe the direct effect of the block nor the interaction on
the dependent variable. The term which is allowed to be completely confounded with the
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block is called the defining contrast. The defining contrast is chosen by predicting which
interactions may not be significant or of interest and is usually chosen to be a higher level
interaction.79
In 2k factorial designs, such as the one chosen for this work (Table 5), each factor of
interest has 2 levels (i.e., high and low) for k number of factors. Therefore, there are 2k
combinations of factor levels, which make up the list of design points to be studied.79 If the
factor is listed in the design point, then that factor is held at the high level; if it is not listed,
then it is at the low level. As an example, design point “bc” had the high levels of factor B
and factor C applied to it; while factor A and factor D were at the low levels (Table 6).
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Table 6: Augmented 24 fractional factorial block design for comparison of decontamination parameters.
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In an augmented design, the interaction effects are determined by considering the
product of the individual factors. Using design point “bc” as the example again, the
interaction effect for AB is determined by understanding the product of A·B. In this case,
A is low and B is high. When a negative is multiplied by a positive, the result is negative,
which is indicated in the AB interaction column for design point “bc.”
However, some interaction effects are not observable. Generally, in an augmented
design, no two columns are the exact same or exact opposite of one another, which means
the factors are linearly independent, thus a linear model, such as ANOVA, may be used to
analyze the variance in the resultant data set.79 In Table 6, the columns for “AD,” “BCD,”
“ABC,” and “block” contradict this rule and are said to be completely confounded as a
result. These columns are said to be completely confounded with each other, and thus the
variance in the dataset attributed to these factors cannot be understood with the 24 fractional
factorial block design. These confounding factors are also called the defining contrasts and
are chosen within the block design.
𝑘𝑘
When a 2k design is broken into 2m blocks, the blocks are of the size 2 �2𝑚𝑚 or 2k-m,

where m is the number of blocking factors. Each blocking factor has 2 levels. Each

blocking factor has a corresponding defining contrast, with which it is completely
confounded. These defining contrasts are usually chosen to be high-level interactions, i.e.,
three- and four-factor interactions. Once selected, design points are designated as odd or
even, depending on the number of letters in common with the chosen defining contrast,
distinguishing their level within each block.79 In the specific design chosen for the present
work, ABC was chosen as the defining contrast for block 1, BCD was chosen as the
defining
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contrast for block 2, and as a result AD was completely confounded with the interaction
effect between block 1 and 2.
To date, only limited work using multivariate statistical approaches such as DoE to
compare protocols associated with the pre-treatment of hair has been reported. Those
efforts were focused on examining selected pre-treatment parameters for analysis of the
ethanol consumption biomarker ethyl glucuronide in hair.50,110 The present chapter
describes the application of DoE in the systematic comparison of pre-treatment parameters
for a variety of drugs of abuse. Separate DoE studies were conducted for decontamination
protocols and for all other pre-treatment parameters, including two approaches for final
drug extraction from the hair matrix, which will be described in Chapter V. In the
decontamination study, a 24 fractional factorial block design together with ANOVA and
post-hoc testing were employed with the hypothesis that this approach would demonstrate
the potential utility of DoE to facilitate optimization of pre-treatment parameters in forensic
hair analysis.
4.2 Materials and Methods
4.2.1

Chemicals and Solvents

Solvents and chemicals used for the preparation of mobile phases and sample
preparation for LC-MS analysis (water, methanol, 2-propanol, dichloromethane, formic
acid, ammonium formate) were of HPLC-grade and obtained from Fisher Scientific
(Hampton, NH, USA).
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Stock solutions of AMP, AMP-D11 DZP, HER, COC, DZP-D5, MOR-D3, and COCD3 were obtained at 1.0 mg/mL in methanol from Cayman Chemical (Ann Arbor, MI,
USA). Solutions of Δ9-THC and Δ9-THC-D3 in acetonitrile at 10.0 and 1.0 mg/mL
concentrations, respectively, were purchased from Cayman Chemical. These stock
solutions were used in the preparation of calibration curves. Neat solids of D-AMP sulfate,
DZP, HER, and COC for intentional contamination of hair were purchased from Cayman
Chemical (Ann Arbor, MI, USA). Solids of 1,4-Dithiothreitol (DTT) and Proteinase-K
were purchased from Sigma-Aldrich (St. Louis, MO, USA) Invitrogen (Carlsbad, CA,
USA), respectively. Three kDa molecular weight cut off PTFE spin filters were obtained
from MilliporeSigma (Burlington, MA, USA). Single donor, unprocessed, natural black
color human hair (~300 g) was obtained from a commercial source.
4.2.2

24 Fractional Factorial Design for Comparing Decontamination Protocols

A 24 fractional factorial block design was implemented to understand how the
parameters listed in Table 7 affect the recovery of drug intentionally applied to blank hair
under different decontamination protocols.
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Table 7: Definitions of factors and levels of these factors under study in the 24 fractional
factorial block design.
Factor
A
B
C
D

Decontamination Design
Aqueous decontamination
solvent
Organic decontamination
solvent
Number of consecutive
aqueous washes
Number of consecutive
organic washes

Block 1

Sequence of washes

Block 2

Wash time

(+) 1% SDS
(-) HPLC water
(+) dichloromethane
(-) methanol
(+) 3
(-) 1
(+) 3
(-) 1
(+) Organic before aqueous
(-) Aqueous before organic
(+) 30 min
(-) 30 s

The application of these parameters to hair samples was dictated by the design matrix
(Table 6) and is represented visually in Figure 8. Initially, 30 mg aliquots of blank hair
were externally contaminated with 1 mg of neat solid drug for each replicate (n=3) of each
design point when analyzing for DZP, HER, and COC. The hair and neat solid drug were
added to steel milling jars and shaken in a Mini-BeadBeater 24 ball mill (Biospec;
Bartlesville, OK, USA), without milling beads, for 30 s at 3,200 rpm to homogeneously
coat the hair with drug. Contaminated hair strands were then removed from the milling jar
and transferred to a fresh container for subsequent procedures. The application of THC was
performed by pipetting 1 mL of a 1 mg/mL solution of drug in acetonitrile onto a 30 mg
aliquot of hair. Following vortexing, solvent was evaporated in an Eppendorf Vacufuge
Plus (Hauppauge, NY, USA) under the aqueous vacuum conditions at 45°C for 45 min.
Samples were decontaminated by adding 1 mL of the decontamination solvent/solution and
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agitating for 1 min on an orbital shaker, as specified in the design matrix (Table 6). The
hair samples were then dried overnight.

Figure 8: Analytical scheme for sample preparation for the decontamination DoE studies.
Drug that may have been incorporated deeper into the hair matrix was also determined
following extraction by means of enzymatic degradation of the matrix. Extracted samples
and wash solutions were purified by spin filter and SPE before LC-MS analysis, as
previously described and analysis performed by high performance liquid chromatography
coupled to triple quadrupole mass spectrometry (HPLC-QqQ). The MRM transitions used
for quantitative analysis of are listed in Table 8. A randomized list of design points was
used to determine the order in which samples were prepared and analyzed, with three
replicate samples for each design point. Quantitation of the drug detected in each sample
allowed for subsequent statistical analysis by ANOVA F-Test and Tukey’s HSD to
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determine which, if any, parameters or combination(s) of parameters resulted in significant
differences in the recovery of drug from the washes. Drug recovery from wash solutions
was calculated by summing the amount of drug detected in the sequential washes and
dividing by the difference in the amount of drug left in the milling jar after transfer from
the initial mass of drug initially applied to the hair.
Table 8: MRM transitions used for identification and quantitation of analytes via HPLCMS.
Compound Name
Cocaine
Cocaine-D3
Diazepam
Diazepam-D5
Heroin
Morphine-D3
Δ9-THC
Δ9-THC-D3

4.2.3

MRM Transition(s)
Precursor Ion (m/z) Product Ion (m/z)
182
304
82
185
307
85
222
285
193
198
290
154
211
370
165
126
289
61
193
315
123
196
318
93

Statistical Analysis

The LC -MS analysis allowed for the quantification of drug from all of the samples
analyzed. The quantity of drug detected in the triplicate extracts, using the technique with
the highest recovery, was then employed to find the statistical parameters necessary to
complete an ANOVA table comparing the parameters under study in the DoE matrix. If a

60

significant difference was observed between treatment groups (i.e., design points) by
means of the ANOVA F-test, Tukey’s HSD post-hoc analysis was conducted to determine
which parameters or combinations of parameters resulted in this difference. JMP software
(13th ed.) was used for all statistical analyses.
4.3 Results
Figure 9 shows the plots of the percent recovery of each analyte for each design point
in triplicate. In general, a limited number of design points for each analyte were found to
produce the highest total recovery of drug in the wash solutions. The parameters that were
applied to the samples within these treatment groups were tabulated to draw conclusions
about the most effective decontamination protocols for each analyte. The similarities
between design points with the highest recoveries were used to make a consensus statement
about which of the two levels of each parameter was most effective for removing each of
the analytes from the surface of hair.
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Figure 9: Plot of percent recovery of (A) AMP, (B) DZP, (C) HER, (D) COC, and (E)
Δ9-THC detected in the wash solutions for each design point (n=3). The y-axis is the
percent recovery of the drug; the x-axis is the design point. Points highlighted in red
represent design points with highest recovery. Parameters associated with each design
point are summarized in Table 6.
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The ANOVA comparison of the factors and combinations of factors (Table 9) in
removal of externally contaminated AMP from hair was conducted, resulting in p-values
less than the α-level (0.05) for all factors except B (particle size of homogenized hair) and
C (aqueous decontamination solvent).
Table 9: ANOVA for 24 fractional factorial block design comparing decontamination
parameters for AMP.
Sum of Degrees
Squares Freedom
A
0.45
1
B
0.11
1
C
0.01
1
D
0.33
1
AB
0.63
1
AC
0.65
1
BD
0.59
1
CD
0.47
1
BC
0.13
1
CDA
1.27
1
DAB
1.16
1
ABCD
1.58
1
Number of organic washes
0.06
1
Number of aqueous washes
0.00
1
error
4.51
18
total
5.16
32
Source

Mean Squares

F Ratio

4.54× 10−1
1.13× 10−1
7.00× 10−3
3.34× 10−1
6.32× 10−1
6.48× 10−1
5.92× 10−1
4.68× 10−1
1.26× 10−1
1.27
1.16
1.58
5.75× 10−2
4.06× 10−3
2.51× 10−1
1.61× 10−1

1.81
0.45
0.03
1.33
2.52
2.58
2.36
1.87
0.50
5.05
4.62
6.32
0.23
0.02

pvalue
0.19
0.51
0.86
0.26
0.38
0.12
0.14
0.18
0.48
0.03
0.04
0.02
0.63
0.88

Figure 9A shows the recovery of AMP in the combined aqueous and organic washes
for each design point. Average recovery was highest for design points ad, bc, and abd at
100%. The extracts of these samples were analyzed for AMP content, all indicating
concentrations below the limit of detection. The conditions under which recovery was
highest are summarized in Table 10. Design points ad and abd shared several
decontamination conditions including the aqueous decontamination solvent (1% SDS), the

63

number of aqueous and organic washes applied to the samples (1 and 3, respectively), the
order in which the washes were conducted (aqueous before organic), and the length of
washes (30 s). Design points bc and abd were similar in that they both employed
dichloromethane as the organic decontamination solvent.
Table 10: List of parameters for the design points resulting in the highest recovery of
AMP.
Wash Parameter
A: Aqueous decontamination solvent
B: Organic decontamination solvent
C: Number of aqueous washes
D: Number of organic washes
Block 1: Sequence of washes
Block 2: Wash time
Drug Recovered in Washes

Design Point
ad
bc
abd
1% SDS
HPLC water
1% SDS
MeOH
DCM
DCM
1
3
1
3
1
3
Aqueous first Organic first Aqueous first
30 s
30 min
30 s
100±5%
100±8%
100±12%

The ANOVA F-Test results for the decontamination of DZP (Table 11) indicated that
significant individual and combinatorial factors (i.e. p-value < α-level, 0.05) included
aqueous decontamination solvent/solution (A), the combinatorial effect of aqueous
solvent/solution and the organic decontamination solvent (AB), the combinatorial effect
between aqueous solvent/solution and number of consecutive aqueous washes (AC), the
combinatorial effect of organic solvent and number of organic washes (BD), the
combinatorial effect of aqueous solvent/solution, organic solvent, and number of
consecutive aqueous washes (ACD), the combinatorial effect of aqueous solvent/solution,
organic decontamination solvent, and number of consecutive organic washes (ABD), and
the combinatorial effect of all main factors (ABCD).
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Table 11: ANOVA for 24 fractional factorial block design comparing decontamination
parameters for DZP.
Source
A
B
C
D
AB
AC
BD
CD
BC
CDA
DAB
ABCD
Number of organic
washes
Number of aqueous
washes
error
total

Sum of Degrees
Squares Freedom
2416.16
1
29.15
1
76.07
1
59.34
1
3211.56
1
5223.76
1
1329.12
1
366.39
1
223.27
1
6134.08
1
3741.10
1
10121.44
1
770.01

1

1406.87

1

8979.51
19100.95

32
47

Mean
Squares
2.42 × 103
2.91 × 101
7.61 × 101
5.93 × 101
3.21 × 103
5.22 × 103
1.33 × 103
3.66 × 102
2.23 × 102
6.13 × 103
3.74 × 103
1.01 × 104
7.07 × 102
1.41 × 103

F Ratio
8.61
0.10
0.27
0.21
11.44
18.62
4.74
1.31
0.80
21.86
13.33
36.07

p-value
0.006139
0.753883
0.606908
0.649864
0.001911
0.000143
0.036956
0.260884
0.377772
0.000051
0.000923
<0.00001

2.74 0.107641
5.01 0.032287

2.81 × 102
4.06 × 102

Recoveries of DZP in wash solutions ranged from 40 ± 15% to 94 ±18%, with the

highest recoveries noted for design points c, ad, and abcd (Figure 9B). Decontamination
parameters for these optimal design points are summarized in Table 12. Blocking factors
1 and 2 were just the same for all of the samples in the treatment groups associated with
these design points, employing the organic wash before the aqueous wash and
decontaminating for 30 min during each wash step. Design points ad and abcd had in

common the use of 1% SDS as the aqueous decontamination solution. Additionally, three
sequential organic washes were applied to samples for design points ad and abcd. Design
points c and ad had in common the use of methanol as the organic decontamination solvent.
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Design points c and abcd both utilized three consecutive washes with the aqueous
decontamination solvent/solution.
Table 12: List of parameters for the design points resulting in the highest recovery of
DZP.
Wash Parameter
A: Aqueous decontamination solvent
B: Organic decontamination solvent
C: Number of aqueous washes
D: Number of organic washes
Block 1: Sequence of washes
Block 2: Wash time
Drug Recovered in Washes

c
HPLC Water
MeOH
3
1
Organic first
30 min
76±24%

Design Point
ad
1% SDS
MeOH
1
3
Organic first
30 min
94±18%

abcd
1% SDS
DCM
3
3
Organic first
30 min
80±20%

The ANOVA F-Test results for the decontamination of HER (Table 13) indicated that
all individual factors and combinations of factors resulted in p-values less than the α-level
(0.05) and thus were significant.
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Table 13: ANOVA for 24 fractional factorial block design comparing decontamination
parameters for HER.
Source
A
B
C
D
AB
AC
BD
CD
BC
CDA
DAB
ABCD
Number of organic
washes
Number of aqueous
washes
error
total

Sum of
Degrees
Squares Freedom
3885.39
1
273.60
1
3276.92
1
1135.55
1
8668.40
1
7203.75
1
28098.67
1
8388.59
1
14513.94
1
25506.01
1
26032.72
1
76318.13
1
533.91
1
5439.08

1

1154.95
77473.08

32
47

Mean
Squares
3.89 × 103
2.74 × 102
3.28 × 103
1.14 × 103
8.67 × 103
7.20 × 103
2.81 × 104
8.39 × 103
1.45 × 104
2.55 × 104
2.60 × 104
7.63 × 104
5.34 × 102
5.44 × 103

F Ratio

p-value

107.65
7.58
90.79
31.46
240.17
199.59
778.52
232.42
402.13
706.69
721.28
2114.53
14.79

<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001

150.70

<0.00001

3.61 × 101
1.65 × 103

Recoveries of HER in wash solutions ranged from 12 ± 3%_ to 124 ± 18%, with design

points ab, bd, and cd demonstrating the highest total recoveries of HER (Figure 9C).

Decontamination parameters for these design points are summarized in Table 14. While
the variation within these design points is high, it is clear that they resulted in the highest
recoveries of HER and allowed for the common variables to be noted for design points bd
and cd included HPLC water as the aqueous decontamination solvent, three consecutive
organic washes before the aqueous wash, and decontamination for 30 s during each wash
step. Commonalities between design points ab and bd included DCM as the
decontamination solvent and only one aqueous wash applied to the hair.
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Table 14: List of parameters for the design points resulting in the highest recovery of
HER.
Wash Parameter
A: Aqueous decontamination solvent
B: Organic decontamination solvent
C: Number of aqueous washes
D: Number of organic washes
Block 1: Sequence of washes
Block 2: Wash time
Drug Recovered in Washes

ab
1% SDS
DCM
1
1
Aqueous first
30 min
109±1%

Design Point
bd
HPLC water
DCM
1
3
Organic first
30 s
124±18%

cd
HPLC water
MeOH
3
3
Organic first
30 s
116±1%

The ANOVA F-Test results for the decontamination of COC (Table 15) indicated that
all individual factors and combinations of factors resulted in p-values less than the α-level
(0.05), and therefore had a significant effect.
Table 15: ANOVA for 24 fractional factorial block design comparing decontamination
parameters for COC.
Source
A
B
C
D
AB
AC
BD
CD
BC
CDA
DAB
ABCD
Number of organic
washes
Number of aqueous
washes
error
total

Sum of
Degrees
Squares Freedom
331.70
1
1120.58
1
237.46
1
5854.62
1
3316.10
1
1867.88
1
7967.76
1
6622.32
1
1358.04
1
1341.63
1
10046.67
1
13754.42
1
979.19

1

27.76

1

592.16
14346.58

32
47
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Mean
Squares
3.32 × 102
1.12 × 103
2.37 × 102
5.85 × 103
3.32 × 103
1.87 × 103
7.97 × 103
6.62 × 103
1.36 × 103
1.34 × 103
1.00 × 104
1.38 × 104
9.79 × 102
2.78 × 101

1.85 × 101
3.05 × 102

F Ratio
17.93
60.56
12.83
316.38
179.20
100.94
430.58
357.87
73.39
72.50
542.92
743.28

p-value
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001
<0.00001

52.91 <0.00001
1.50

0.10108

Recoveries of COC in wash solutions ranged from 61 ±9%to 119 ± 1%, with the

highest recoveries observed for design points bd, abd, acd, and abcd (Figure 9D).

Decontamination parameters for these design points are summarized in Table 19. Each of
these design points employed three consecutive organic washes. Design points bd, abd, and
acd each used a single aqueous decontamination wash for 30 s. The aqueous
decontamination solution applied to samples in treatment groups abd, acd, and abcd was
1% SDS. The organic decontamination solvent applied to samples in treatment groups bd,
abd, and abcd was DCM. Design points abd and acd represented treatment with the aqueous
decontamination solvent/solution first, whereas bd and abcd utilized organic solvent first.
Table 16: List of parameters for the design points resulting in the highest recovery of
COC.
Wash Parameter
A: Aqueous decontamination
solvent
B: Organic decontamination
solvent
C: Number of aqueous washes
D: Number of organic washes
Block 1: Sequence of washes
Block 2: Wash time
Drug Recovered in Washes

Design Point
abd
acd
1% SDS
1% SDS

bd
HPLC
water
DCM
1
3
Organic
first
30 s
111±1%

abcd
1% SDS

DCM

MeOH

DCM

1
3
Aqueous
first
30 s
115±3%

1
3
Aqueous
first
30 s
112±4%

3
3
Organic
first
30 min
119±1%

The ANOVA F-Test results for decontamination of THC (Table 17) indicated that
individual factors A and B, along with all combinations of factors, resulted in p-values less
than the α-level (0.05).
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Table 17: ANOVA for 24 fractional factorial block design comparing decontamination
parameters for THC.
Source
A
B
C
D
AB
AC
BD
CD
BC
CDA
DAB
ABCD
Number of organic washes
Number of aqueous washes
error
total

Sum of Degrees
Squares Freedom
2623
1
171
1
2262
1
9
1
2914
1
5147
1
3761
1
2767
1
2444
1
6867
1
10056
1
978
1
318
1
1149
1
2742
16
18391
31

Mean
Squares
2623
171
2262
9
2914
5147
3761
2767
2444
6867
10056
978
318
1149
171
593

F Ratio

p-value

15 0.00135
1 0.33220
13 0.00237
0 0.82151
17 0.00080
30 0.00005
22 0.00025
16 0.00103
14 0.00178
40 0.00001
59 <0.00001
6 0.02170
2 0.17646
7 0.01762

Recoveries of THC in wash solutions ranged from 22 ± 9% to 83 ± 10%, with highest

recoveries detected for design points bc, ac, d, cd, and b (Figure 9E). Decontamination
parameters for these design points are summarized in Table 18. Design points bc, d, cd,

and b utilized HPLC water as the aqueous decontamination solvent, and design points bc,
ac, and d included application of the aqueous wash prior to the organic. Design points bc,
ac, and cd had in common the use of three consecutive aqueous washes, while design points
bc, ac, and b all employed a single organic wash. A 30 min was utilized for design points
ac, d, and b.
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Table 18: List of parameters for the design points resulting in the highest recovery of Δ9THC.
Wash Parameter
A: Aqueous
decontamination
solvent
B: Organic
decontamination
solvent
C: Number of
aqueous washes
D: Number of
organic washes
Block 1: Sequence
of washes
Block 2: Wash time
Recovered Drug in
Wash

Design Point
d

cd

b

1% SDS

HPLC
Water

HPLC
Water

HPLC
Water

DCM

MeOH

MeOH

MeOH

DCM

3

3

1

3

1

1

1

3

3

1

Aqueous
first
30 s

Aqueous
first
30 min

Aqueous
first
30 min

Organic
first
30 s

Organic
first
30 min

77±11%

72±14%

74±14%

83±9%

78±17%

bc

ac

HPLC
Water

Consensus parameters that resulted in the highest recovery for each analyte are
summarized in Table 19. These data indicate that the optimal combination of
decontamination parameters was different for each individual drug.
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Table 19: Summary of the parameters resulting in the highest average recovery of
analytes.
Wash Parameter
A: Aqueous
decontamination solvent
B: Organic
decontamination solvent
C: Number of aqueous
washes
D: Number of organic
washes
Block 1: Sequence of
washes
Block 2: Wash time

AMP
1% SDS

DZP
1% SDS

COC
1% SDS

MeOH

Δ9-THC
HPLC
Water
MeOH

DCM

HER
HPLC
Water
DCM

DCM
1

3

3

1

1

3

3

1

3

3

Aqueous
first
30 s

Organic
first
30 min

Aqueous
first
30 min

Aqueous
first
30 s

Organic
first
30s

4.4 Discussion
In the present study, a DoE matrix combined with ANOVA F-test analysis was
employed to systematically assess the effects of two levels of four different independent
decontamination parameters on recovery of four physically and chemically diverse drugs
from externally contaminated hair. Unlike previous studies, the DoE approach allowed for
the determination of multiple significant factors impacting the decontamination of each
analyte in a single experiment. In addition, DoE allowed the determination of the effects
of combinations of decontamination factors (e.g., solvents, wash times, order of washes,
etc.), a capability that facilitates the study of the impact of changing multiple variables
within the experiment. The present report is the first in which multiple parameters in hair
decontamination were simultaneously compared for a variety of drugs. Results of the
ANOVA F-Test for COC and HER showed that all the individual sources (i.e., A, B, C,
and D) were significant. In contrast, for DZP and THC, only one or two of the individual
sources, respectively, were significant. Perhaps more importantly, higher-level interactions
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(e.g., AB, ABC, etc.) were significant for all four drugs, indicating that combinations of
the variables had a significant effect on the level of drug detected in the wash solutions.
There are several previous reports that compared wash protocols following SoHT
guidelines.75,76,111 These studies concluded that methanol was most effective organic
solvent at removing surface contamination, while 1% SDS was the most effective aqueous
decontamination solution for the removal of a variety of analytes.75,76,111 Some previous
observations are in contrast to findings reported herein. For example, in the present study,
DCM was found to be more effective than methanol at removing COC from the hair
surface. Other work has shown that, for removal of THC contamination, SDS was the most
effective aqueous solvent/solution, while methanol, DCM, and chloroform were effective
organic solvents.76 In contrast, in the present study it was found that water and methanol
were the most effective solvents for removing THC from hair. Some of these
inconsistencies may be attributable to differences in experimental approach, primarily
regarding the contamination process; other studies have used a drug-containing solution of
synthetic sweat or have burned marijuana in a chamber that contained hair to contaminate
its surface with THC.67,105 Additionally, it may not be valid to directly compare results
from hair decontamination studies using a “one factor at a time” approach to those
generated using a multivariate technique such as DoE.
There are numerous methods that are commonly referenced for decontamination of hair
samples prior to toxicological analysis. For example, Wang and Cone reported a
decontamination technique that called for submersion of the hair samples in methanol for
~1 min.112 A method in which hair was vortexed in DCM three times for 5 min each was
reported by Kintz.113 Another method reported initially by Cairnes et al. included first
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vigorously agitating hair in n-propanol for 15 min at 37°C, then in 0.01 M PBS containing
0.01% bovine serum albumin, pH 6, twice for 30 min each, and finally with the same buffer
twice for 60 min each.72 A more complex method, reported by Baumgartner and Hill,
included staining with methylene blue to assess the porosity of the hair sample, followed
by washing with ethanol for 15 min at 37°C with shaking. More porous samples were then
washed with a mixture of ethanol and water. Non-porous and slightly porous hair were
washed with 0.01 M PBS, pH 5.6; 30-min washes were conducted in sequence with the
aqueous solution until the concentration of drug in the washes reached a plateau.73
Stout et al. compared the methods reported by Cairnes et al. and Baumgartner and Hill
to determine which was most effective at removing COC from the surface of hair that was
intentionally contaminated and then exposed to a synthetic sweat solution. Neither method
was found to be successful for complete removal of drug applied to the hair, a result
consistent with a number of other studies aiming to remove COC external
contamination.66,69,72,75,109,112 These authors also studied the effects of different
decontamination methods on hair morphology by means of scanning electron microscopy,
finding that each method could be associated with some level of damage to hair
structures.70 Observed damage included lifting of the cuticle cells, changes to the cell
membrane complex between cuticle cells, and substantial degradation of the cuticle, which
in some cases resulted in complete loss of cuticle cells. Finally, Cuypers et al. reported that
the use of certain solvents for the purpose of decontamination may in fact encourage the
migration of the drug into deeper hair structures, questioning the currently held approaches
for decontamination procedures.66
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While much investigation into the decontamination of COC from hair has been
conducted, there are fewer reports examining other common drugs of abuse. Tsanaclis et
al. applied the use of ratios of drug present in wash solutions and extracts to the
decontamination of THC, finding that two washes of less than 1 min each with methanol
were sufficient.105 Duvivier et al. tested a series of washes for the removal of THC from
the surface of hair, finding that the most effective methods were multi-step processes with
methanol and SDS.76 Mantineiks et al. studied the decontamination of hair intentionally
contaminated with methamphetamine, finding that, compared to heptane, DCM,
acetonitrile, and 2-propanol, methanol was the most effective organic decontamination
solvent for this compound.75 The results of the present work support the data reported by
Baumgartner and Hill, in that a minimum of four washes is necessary to sufficiently
decontaminate the surface of hair. Though the specific parameters under which the
maximum amount of drug was removed from the surface of hair was analyte specific, as
noted in each of the previously mentioned works.
The reported applications of DoE to optimizing conditions for forensic hair analysis are
currently quite limited. Mueller et al. compared a number of pre-treatment parameters in
the analysis of ethyl glucuronide in hair using a Plackett-Burman experimental design.110
However, the Plackett-Burman design does not consider combinatorial effects of the
factors under study on the dependent variable. Alladio et al. used a 2-factor full factorial
design to investigate and optimize the extraction of ethyl glucuronide from hair.50
An important result of the present study, as compared with previously reported
decontamination results, is that only a limited number of treatments for each drug were
found to be most effective at decontaminating the surface of hair. For example, effective
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decontamination of HER was associated with only a small number of design points, with
much poorer results demonstrated for the other combinations. Conclusions about the most
effective decontamination protocols for each analyte can be drawn from the commonalities
between the treatment groups (i.e., design points), as summarized for the present study in
Table 19. One might be tempted to rationalize these optimal conditions using drug
solubility, polarity, ionization parameters, and the penetrability of the hair sample, all of
which have been hypothesized to influence the efficacy of wash parameters.75 However, it
must be noted that the mechanisms of surface binding of drugs to hair components are
poorly understood, making predictions about optimal wash conditions difficult at best.
Furthermore, the major advantage of the DoE approach as applied herein is to elucidate
combinations of parameters that would result in effective removal of surface
contamination, a goal that would be challenging to accomplish a priori based on
consideration of physicochemical characteristics alone.
4.5 Conclusions
The present study demonstrated proof of principle for the successful use of a DoE
approach to identify effective combinations of experimental parameters for hair
decontamination for a physically and chemically diverse group of drugs. The use of a 24
fractional factorial block design for this purpose is a novel approach and provides
additional insight into the effect of all considered wash parameters simultaneously, which
has not been reported to date. Each of the analytes under study was found, within a limited
set, to have a unique set of decontamination conditions that were most effective. Additional
studies are necessary to test the applicability of the DoE approach and the optimized
decontamination methods identified in the present study with authentic hair specimens.
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5. SYSTEMATIC COMPARISON OF EXTRACTION PARAMETERS IN FORENSIC
HAIR ANALYSIS VIA 23 FULL FACTORIAL DESIGN
5.1 Introduction
In addition to the specific attention given to the decontamination protocol as described
above, it is important to compare the remaining pre-treatment parameters, particularly
those involved in the extraction of incorporated drug from hair. The most commonly used
methods for the extraction of drug from hair include acidic, alkaline, or enzymatic
degradation of the proteinaceous matrix or solvent swelling to release drug by passive
diffusion, much like the technique used to incorporate/entrap drugs to generate HRM.39,47,51
Within these techniques, drug can be extracted for different amounts of time, at different
temperatures, and with varying ratios of extraction agent to the mass of hair from which
analytes are to be isolated.
Much of the published literature that exists comparing different techniques that have
been successfully employed for the pre-treatment of hair samples and their subsequent
analysis are review articles that tabulate results of these different approaches without
comparing their performance.6,39,41,43,45,114–116 In contrast, Wada et al. used a different
approach to reviewing existing methods by comparing established techniques by the class
of drug, using the LOD/LOQ to determine the efficacy of these methods.44 Previous work
aiming to more specifically study pre-treatment parameters has been primarily focused on
individual factors. For example, Salomone et al. determined that pulverizing hair into a
powder before determining the ethyl glucuronide (EtG) content was more effective than
cutting the hair into snippets.49 Studies conducted by Romano et al. and Stout et al. sought
to compare whole decontamination protocols that were previously established for removal
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of COC, both finding that different decontamination protocols resulted in different amounts
of drug removed from hair. They also determined that these protocols were insufficient in
removing all of the contamination and, in the worst cases, actually encouraged
incorporation of contaminating drug into the hair.69,74
Broecker et al. studied the effect of heat and ultrasonication on the efficacy of the
solvent extraction technique commonly used in hair testing, finding that, while
ultrasonication did not improve extraction of 17 drugs and metabolites from hair,
maintaining a temperature of 37°C throughout the extraction did.51 Duvivier et al. studied
a variety of aqueous and organic decontamination solvents as single washes and in different
combinations for the removal of Δ9-THC from the surface of hair, finding that there were
several adequate sequences of washes that were equally effective.76 Madry et al. studied
the efficacy of different extraction solvents for a wide variety of drugs and their
metabolites, concluding that acidified methanol was most effective for the largest number
of compounds in the study.117 However, none of these works directly compared all of the
parameters that must be considered when deciding the pre-treatment parameters to apply.
A few recent studies have applied DoE techniques to hair analysis parameters on a
limited basis. For example, Mueller et al. studied whole extraction protocols for isolating
ethyl glucuronide (EtG), a metabolite routinely analyzed in hair as a marker for ethanol use
and abuse, from hair.110 They compared several pre-treatment parameters, including
extraction solvent, the use of ultrasonication, incubation time, incubation temperature,
solvent amount, and hair particle size using a Plackett-Burman experimental design.110 This
design assumes that the 2-factor effects (i.e., interactive effects coming from 2 factors as
opposed to a single factor) are negligible. The factors identified to have significant
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influence on the detection of EtG included type of extraction solvent, extraction
temperature, and particle size of the homogenized hair.110 Another study by Alladio, et al.
supported these results and investigated their own optimized and validated methodology.
First, a 2-factor full factorial design was used to investigate extraction temperature and
solvent formulation. The optimization design was a face-centered central composite design
comparing extraction time, temperature, and pH.50 While useful, these Plackett-Burman
experimental designs fail to address combinatorial effects. In the present study, the DoE
approach was a 23 full factorial design, as employed in the present work, allowed for the
observation of both the individual and combinatorial effects of the parameters under study
for a wider range of parameters than previously reported as there were three factors under
study: extraction time, extraction temperature, and extraction agent to mass of hair ratio.
Consequently, a 23 design was employed (Table 20) under the hypothesis that DoE could
be used to determine which extraction parameters were best for each analyte and illustrate
similarities between extraction parameters that may be adequate for all analytes under
study.
Table 20: 23 Full Factorial Design for the Comparison of Extraction Parameters
Design Point
(1)
a
b
c
ab
ac
bc
abc

A
+
+
+
+

B
+
+
+
+

C
+
+
+
+
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AB
+
+
+
+

AC
+
+
+
+

BC
+
+
+
+

ABC
+
+
+
+

5.2 Materials and Methods
5.2.1

Chemicals and Solvents

Solvents and chemicals used for the preparation of mobile phases and sample
preparation for LC-MS analysis (water, methanol, 2-propanol, dichloromethane, formic
acid, ammonium formate) were of HPLC-grade and obtained from Fisher Scientific
(Hampton, NH, USA). Stock solutions of AMP, AMP-D11 DZP, HER, COC, DZP-D5,
MOR-D3, and COC-D3 were obtained at 1.0 mg/mL in methanol from Cayman Chemical
(Ann Arbor, MI, USA). Δ9-THC and Δ9-THC-D3 were purchased from Cayman Chemical
as 10.0 and 1.0 mg/mL solutions in acetonitrile, respectively. These stock solutions were
used in the preparation of the wet chemistry-based incorporated HRM and calibration
curves. DTT was purchased from Sigma-Aldrich (St. Louis, MO, USA), and Proteinase-K
was obtained from Invitrogen (Carlsbad, CA, USA). Three kDa molecular weight cut off
PTFE spin filters were obtained from MilliporeSigma (Burlington, MA, USA). Single
donor, unprocessed, natural black color human hair (~300 g) was obtained from a
commercial source.
5.2.2

23 Design Matrix for Comparison of Extraction Technique

In general, and depicted in Figure 10 the DoE samples were prepared by first weighing
30 mg of the incorporated HRM into a 20 mL amber vial. The aqueous wash was performed
by adding 1 mL aqueous decontamination solvent and agitating on an orbital shaker for 1
min. Next, the organic wash was performed with 1 mL of solvent and agitation on an orbital
shaker for 1 min. The decontamination conditions applied were those that were established
to be most effective in the previous chapter. The hair was then dried for 24 h at 37°C in a
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temperature-controlled oven. Once dried, the samples were either cut into snippets or
powdered. Samples that were to be snippets were cut with surgical scissors into ~1 mm
segments. Samples that were powdered were milled with 10 chrome-steel milling beads in
chrome-steel milling tubes using a Mini-BeadBeater 24 ball mill (Biospec; Bartlesville,
OK, USA) at 3200 rpm for 30 s. Drug was then extracted using one of the two previously
described techniques, enzymatic degradation or solvent swelling of the hair matrix, with a
volume of extraction agent.

Figure 10: Schematic of sample preparation for extraction DoE studies.
Table 21 defines each factor and each level of these factors that was studied in the DoE
designs, and Table 20 outlines the 23 full fractional design used to study these parameters.
Each design point in Table 20 correspond to a single sample to which different levels of
these parameters were applied. Extracted samples were purified by centrifugation and SPE
before LC -MS analysis, as described in the previous chapter. A randomized list of design
points was used to determine the order in which samples were prepared and analyzed.
Three replicate samples for each design point as listed in Table 20 were analyzed. One
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replicate study of the entire DoE protocol was conducted for each of the two extraction
techniques.
Table 21: Definition of factors and factor levels for each experimental design.
Factor

Pre-treatment Design

A

Extraction solvent volume ratio to sample size

B

Particle size of homogenized hair

C

Extraction Time

(+) 25 µL/mg
(-) 12.5 µL/mg
(+) 1 mm snippets
(-) powder
(+) 24h
(-) 2h

5.2.3 Statistical Analysis
LC-MS analysis allowed for the quantification of drug from all of the samples analyzed.
The replicate samples containing drug isolated using each extraction technique were
compared by means of a Student’s t-test to determine which, if either, of the techniques
resulted in more efficient isolation of the analyte from the matrix.
The quantity of drug detected in the triplicate extracts, from the technique with the
highest recovery, was then used to find the statistical parameters necessary to complete an
ANOVA table comparing the parameters under study in the DoE matrix. If a significant
difference was observed between treatment groups (i.e., design points) by means of the
ANOVA F-test, Tukey’s HSD post-hoc analysis was conducted to determine which
parameters or combinations of parameters resulted in this difference. JMP software (13th
ed.) was used for all statistical analyses.

82

5.3 Results
5.3.1 Comparison of Extraction Technique
A pooled Student’s t-test indicated which of the two extraction techniques resulted in
the highest extraction of each analyte, as seen in Figure 11. The enzymatic degradation
technique was significantly (α = 0.05) more effective at extracting AMP (p = 0.01) and the
solvent swelling technique was most effective at extracting DZP (p = 0.001). There was no
significant difference in the extraction of THC between the two techniques (p = 0.7),
though the mean of the samples extracted by the solvent technique was slightly higher than
that of the enzymatic degradation technique; thus the solvent technique was used in the
subsequent experiments for DZP and THC and the enzymatic degradation technique was
used for AMP.
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Figure 11: Comparison of extracted drug with different extraction techniques. Points
represent each sample extracted using the designated technique (n=48), with different pretreatment protocols as outlined in the DoE matrix. The outlines in green represent the
quantiles of the data. Solid, central, horizontal line represents the average extracted
quantity for each technique for AMP (A), DZP (B), and THC (C).
5.3.2 DoE Comparison of Extraction Conditions
ANOVA F-Test indicated that all factors and their combinations were significant, with
p-values less than 0.05 (i.e., the α-level). Each analyte under study had different conditions
under which extraction was the highest. Extraction conditions associated with design point
c resulted in the highest extracted quantity of AMP, at 4,316 ± 96 pg (Figure 12A). The
specific conditions applied to the samples in the treatment group associated with design
point c were extracting drug from hair that was pulverized into a powder before being
exposed to 12.5 µL of extraction solvent/mg of hair for 24 h. The conditions under which
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the most DZP, at 122 ± 1 pg (Figure 12B), was isolated from the incorporated HRM were
associated with design point b; this means that DZP was extracted from samples in this
treatment group by cutting the hair into 1 mm snippets and applying 12.5 µL of extraction
solvent/mg of hair for 2 h. The greatest amount of THC extracted, at 115 ± 1 pg, was
observed for samples in the treatment group corresponding to design point ab (Figure 12C).

THC was extracted from samples in this group by cutting the hair into 1 mm snippets and
exposing them to 25 µL of extraction solvent/mg of hair for 2 h.
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Figure 12: Comparing the effect of the variation in extraction parameters on the amount
of extracted drug for AMP (A), DZP (B), and THC (C).
5.6 Discussion
All factors and combinations of factors in the DoE studies of hair pre-treatment
conditions were found to be significant, suggesting that the factors alone did have a
significant effect on the level of drug detected in each sample, highlighting the importance
of employing a factorial design to investigate all combinations of parameters, as was noted
by Alladio et al.50 Moreover, the higher-level effects, representing combinations of the
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main effects, also had significant impact on extracted drug quantities, which cannot be
observed using other designs like the Plackett-Burmann design used by Mueller et al.110
This means that it is essential to study pre-treatment conditions as whole protocols, as the
interaction between all of the factors under consideration have a significant effect on the
efficacy of the extraction of drug from the matrix.
AMP was most effectively extracted from the matrix by minimizing the hair particle
size by powdering the hair. This is consistent with previous literature,49 and is likely
because drugs that are incorporated into hair are hypothesized to be localized in the cortex
of the hair.47,96 When the hair strand is pulverized, more of the cortex is exposed to the
extraction solution than when the hair is cut into 1 mm segments. Previous studies have
also shown the significance of particle size on recovery of ethyl glucuronide from hair,
indicating that a smaller sample size results in more efficient extraction of drug.49,76
However, extraction of DZP and THC from hair was maximized by cutting hair into
snippets rather than pulverization; this may be explained by the fact that at a pH of 7.4, as
was the case in the present work, both DZP and THC are neutral while AMP is cationic.
The charged AMP may be held in the matrix by different mechanisms that the DZP and
THC at this pH, which could impact its ability to be released from the matrix, resulting in
different recovery of drug. This technique has also been used successfully for a variety of
analytes.39 The maximization of AMP and DZP extraction was achieved with 12.5 µL of
extraction solvent/mg of hair, where THC required 25 µL of extraction solvent/mg of hair.
Previous studies on ethyl glucuronide indicated that the optimal conditions for extraction
were at 25 µL of extraction solvent/mg of hair.50,110 EtG has a TPSA of 116 Å2 and a pKa
of 3.5; thus at pH 7.4 this very polar molecule is neutral. The analytes in the present work
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were much less polar than EtG, which may help to explain the differences in these results.
These same studies indicated that extraction for 24 h was optimal, which is consistent with
the results for AMP.50,110 However, DZP and THC were most effectively extracted after 2
h, which may again be related to the difference in the charge state of these molecules at
physiological pH.
5.7 Conclusions
The highest extraction of AMP, DZP, and THC involved the use of the solvent swelling
technique to isolate drug from hair. This is likely because it is a gentle technique, to
minimize the probability of chemically modifying the analytes, that relies on simple
diffusion for the release of drug from hair. Although one of the aims of this work was to
find similarities in pre-treatment conditions between different analytes, results indicate that
each analyte must be considered individually, as the conditions under which the most drug
will be extracted from hair varies. Neutral compounds were more effectively isolated from
the matrix with shorter extraction times and larger particle sized of the homogenized hair,
while the cationic AMP required smaller particle size and longer extraction for effective
extraction.
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6. PROBING INTERACTIONS BETWEEN DRUGS OF ABUSE AND EUMELANIN
6.1 Introduction
It is clear that drugs of abuse can become trapped within human head
hair4,11,98,99,13,15,20,45,54,55,64,96, which necessitates the question: how do these substances
remain held within the hair? It has been demonstrated that drugs can associate with
melanin.2,4,104,18,20–22,47,99,102,103 As discussed in Chapter 1, there are two main subclasses of
melanins: eumelanin and pheomelanin. Eumelanin is the pigment primarily associated with
brown/black hair coloration; much of the research regarding the association of drugs of
abuse with matrix components have referenced the ability of drugs to interact with
eumelanin.4,15,16,20,118–121 Different amounts of the subclasses of melanin are present within
the hair of people from different ethnic and racial backgrounds; these inter-individual
differences in pigmentation may lead to complications in the interpretation of toxicological
analyses using hair.5
While it has been demonstrated that eumelanin and drugs can interact with one another
as a mechanism by which drugs may be retained in hair, the nature of these associations is
not well understood. It has been suggested that basic, lipophilic drugs may have a greater
affinity for binding/interacting with melanin.47 The preferential binding of basic drugs
would be favored as a result of anionic carboxylic acids on the structure of melanin,
indicated in Figure 13, which at the natural pH of hair (i.e., 4.5 - 5.5), up to half of the
carboxylic acids in melanin would be charged.13 This preferential binding is supported by
other data that show the binding preference between compounds with an ionizable primary
amine, like amphetamine, and eumelanin.4,15,20,122 It has also been suggested that peptide
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bonds can form between amine groups and these carboxylic acid functions, especially those
associated with eumelanin.15,20

Figure 13: Monomeric unit of eumelanin.21 The carboxylic acid moieties (highlighted in
blue) have a pKa ~5.0, and have been hypothesized to interact with cationic drug
functionalities under neutral and alkaline conditions (i.e., pH ≥ 7), in which these
carboxylic acids would be deprotonated, and therefore anionic.
A study by Cappelle et al. compared the detection of drugs of abuse in hair and nails,

both keratinous matrices formed from type I and type II IFs.123 The notable differences in
the matrices were the mechanisms by which drugs could become incorporated into the
matrix and the presence or absence of melanin.123 Drugs can become incorporated into hair
by means of drug-containing blood flow to the follicle, while drugs can become
incorporated into nails by means of blood flow to the nail matrix and the nail bed, resulting
in vertical and horizontal incorporation of drug into the nail. Hair contains melanin,
whereas nails do not; some substances in hair have shown a positive relationship with
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melanin content.3–5,7,20,25,47,123 The substances most noted to associate with eumelanin have
been basic compounds. However, it is still possible to detect drugs of abuse in melaninfree nail matrices. Therefore, it is clear that drugs of abuse can associate with the keratinous
matrix and/or melanin, when it is present.
Several analytical techniques have been employed to investigate the associations
between xenobiotics and melanin including NMR, liquid scintillation counting, UV/Vis,
and MS. Salazar-Bookaman et al. studied the interaction of drugs with a synthetic, water
soluble eumelanin-related compound, (-)-dopa melanin, via line width measurements
acquired using a pulse NMR instrument. The spectra of dilute melanin mixed with
ophthalmologic pharmaceuticals (i.e., atropine, acetylcholine isoprenaline bitatrate,
ephedrine, and timolol meleate) demonstrated line broadening of the peaks associated with
the N-alkyl protons on the respective structures as compared to the spectra of these
compounds in the absence of melanin.124 A specific example from this work, is given for
ephedrine (Figure 14).

Figure 14:Structure of ephedrine. The protons of interest for the study of the dissociation
constant with melanin were the N-methyl protons implicit in the blue highlighted area.
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The line broadening of the N-methyl protons at 2.57 ppm, as noted in Figure 15, were
recorded as drug was titrated into a dilute solution of the water-soluble melanin to then
calculate the dissociation constant.

Figure 15:Spectra of ephedrine in the absence of melanin (bottom spectrum) and in the
presence of melanin (top two spectra). The assignments of some spectral peaks are noted
at the top of the figure. The N-methyl peaks, at 2.57 ppm, were noted to broaden in the
presence of melanin and remain broad after 48 h and 144 h.124
The upward curve of the fitted trendline, as seen in Figure 16, indicated that there was more
than one binding site on melanin that ephedrine interacted with, with dissociation constants
for these sites reported as Kd1 = 2.08 mM and Kd2 >20 mM.124
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Figure 16: Fitted trendline for the change in the line width of 2.57 ppm peak of ephedrine
titrated into melanin.124
Another approach to studying these interactions is through the use of radiolabeled drugs
and liquid scintillation counting. Shimada et al. studied the association between
radiolabeled drugs in a PBS buffer at pH 7.4 and eumelanin by titrating the melanin into
the solutions of drug and quantitating the unbound drug. The free drug concentration was
plotted against that of the bound drug and fit to a linearized Langmuir isotherm model, as
shown in Figure 17.16
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Figure 17: Linearized Langmuir isotherms of AMP, ephedrine, octopamine, COC, and
norepinephrine.16
The binding constants for the drugs of abuse were calculated from the Langmuir fitted
curves, as reported in Table 22. The highest melanin affinity was observed for COC (+)
AMP, epinephrine and (-) AMP, at 8.9 × 105 𝑀𝑀−1, 2.8 × 105 𝑀𝑀−1, 2.6 × 105 𝑀𝑀−1, and
1.1 × 105 𝑀𝑀−1 respectively.16
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Table 22: Linearized Langmuir fit parameters and calculated melanin affinities for AMP
ephedrine, octopamine, norepinephrine, atropine, and COC.16
Drug

(-)-Amphetamine
(+)-Amphetamine
(±)-Epinephrine
(-)-Ephedrine

(±)-Octopamine

(+)-Norepinephrine
Atropine

a

(±)-Cocaine

Slope× 10−3
(Lower/Upper
Limit)a

Intercept× 10−3
(Lower/Upper
Limit)a

2.7
(2.5/2.9)
2.1
(1.7/2.4)
3.5
(3.1/3.9)
4.0
(3.3/4.8
2.8
(2.2/3.3)
2.7
(2.4/3.1)
2.3
(2.1/2.4)
0.48
(0.45/0.51)

3.1
(-0.4/6.6)
5.7
(1.0/10)
0.25
(-4.1/4.6)
5.6
(-0.6/11.7)
7.2
(0.8/14)
5.8
(1.4/10)
0.57
(0.07/1.1)
4.2
(2.8/5.7)

Maximum
Moles Bound
per Milligram
of Melaninb
3.2 × 10−9

Affinityc, M-1

39.7 × 10−9

0.072 × 105

1.4 × 10−9

2.6 × 105

1.8 × 10−9
1.8 × 10−9
1.7 × 10−9

17.6 × 10−9
2.4 × 10−9

1.1 × 105
2.8 × 105
1.4 × 105
2.1 × 105

0.25 × 105
8.9 × 105

95% confidence intervals calculated at p = 0.05. b Calculated as the reciprocal of the yintercept. c Calculated from the intercept and slope.
Gautam et al. attempted to study the thermodynamics of the interaction of AMP and
melanin by means of UV/Visible spectroscopy and Scatchard analysis. The effect of
increasing concentrations of melanin on the spectrum of AMP resulted in a bathochromic
shift, peak broadening, and an increase in absorbance at 208 nm, as seen in Figure 18.
These results were interpreted as representing the potential formation of peptide bonds
between the primary amine of amphetamine and the carboxylic acid of melanin, as peptides
exhibit λmax values between 200 and 240 nm resulting from the n  π* transition of the
carbonyl. Observing the changes of the spectrum in the region the authors attribute
specifically to AMP, i.e., between 250 and 265 nm, revealed a decrease in the absorbance
with increasing amounts of melanin. The changes observed at 258.7 nm were used to
perform Scatchard analysis.15
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Figure 18: UV/Vis spectra of AMP with increasing concentrations of melanin.15
It was noted that the association between AMP and synthetic melanin reached
equilibrium when 32% of the AMP in solution was bound to melanin. However, it was not
possible to calculate the association constant via Scatchard analysis, which is a method to
determine binding constants by conducting experiments in which increasing amount of a
ligand are added to a solution of a substrate with which the ligand is known to interact such
that saturation of the interaction site is eventually achieved. Since the exact structures of
and thus the number of interaction/binding sites on melanin polymers are not known, it was
impossible for the authors to determine the saturation point of melanin for the successful
application of Scatchard analysis in this context. However, the curvilinear fit of the
Scatchard plot indicated that there is more than one site at which AMP associates with
melanin, supporting the Scatchard analysis results.15
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Borges et al. used a similar radiolabeling method as Shimada et al. to study the binding
of COC and AMP with eumelanin. Then, the experiments were repeated using LC-QqQ to
quantify the unbound drug after purification by centrifugation. The bound fraction of drug
was determined by mass balance. The data was then fit to a Langmuir isotherm for
estimation of the Ka and Scatchard analysis was performed to determine the number of
binding sites. The Scatchard analysis reportedly indicated two types of binding sites on
melanin: high affinity/low capacity sites and low affinity/ high capacity sites. The Ka was
calculated for each of these sites as reported in Table 23.4 The results obtained differed
from those obtained by Shimada et al., which the authors attributed to the different buffers
used in the two studies. Shimada et al. used a buffer with higher ionic strength, resulting
in a lower Ka value observed for the binding of AMP and COC to melanin as compared to
that of Borges et al.4,16 Since the concentration of the ions in the buffer seemed to have an
effect on the binding of drug to melanin, it is hypothesized that the present research will
find that the physicochemical nature of the binding between drugs of abuse and eumelanin
will be primarily ionic.
Table 23: Association constants between eumelanin and drugs as reported by Borges et
al.4
High Affinity/Low
Capacity
log Ka
-log Bmax
Drug binding to DHI-melanin
Cocaine
8.2 ± 0.19
9.5 ± 0.17
Amphetamine
6.6 ± 0.40
9.3 ± 0.35
Drug binding to DHICA-melanin
Cocaine
7.8 ± 0.14
9.6 ± 0.16
Amphetamine
7.2 ± 1.2
9.9 ± 1.2

Low Affinity/High Capacity
log Ka

-log Bmax

84.9 ± 0.039
3.9 ± 0.34

7.0 ± 0.078
7.0 ± 0.25

4.5 ± 0.29
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NB

7.1 ± 0.082

n = Number of
Binding Sites
2
2
2
1

In addition to the binding studies, Borges et al. performed qualitative LC-MS/MS to
investigate the potential for covalent melanin-drug adducts. Oxidized catechol, reduced
catechol, deprotonated phthalic acid, and 3-methylindole were used as surrogates to
represent functional groups of melanin with the potential for adduct formation with AMP
and COC. The resultant spectra, seen in Figure 19, indicated that there may be non-covalent
adducts formed between AMP and oxidized catechol through hydrogen bonding, as
depicted int the upper-left corner of Figure 19C, suggesting that these adducts may also
form with eumelanin.4
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Figure 19: MS spectra of AMP with oxidized catechol. A: Single stage scan of mixture showing the characteristic peak of AMP at
135.9 m/z and a peak corresponding to the mass of AMP + catechol at 350.1 m/z. B: Product ion scan with Q1 fixed on the m/z of
the potential adduct (350 m/z). C: Neutral loss scan for a loss of a 214 m/z neutral fragment to account for the mass differential
between AMP and the potential adduct.4
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In the present study, drug-melanin associations were studied by UV-Visible
spectroscopy, which is an analytical technique that monitors electronic transitions of
electrons in a system from the highest occupied molecular orbital (HOMO) to the lowest
unoccupied molecular orbital (LUMO) when excited by ultraviolet and/or visible light.
When the light energy applied to the system matches the energy required to promote an
electron from ground to an excited state, energy is absorbed. The spectrophotometer
records the transmittance of light at each wavelength, which is then translated into an
absorbance spectrum. The relationship between absorbance and transmittance is described
in Equation 1.125
𝐴𝐴 = −𝑙𝑙𝑙𝑙𝑙𝑙10 𝑇𝑇

Equation 2

The electronic transitions (i.e., n to π* and π to π*) that are typically recorded are those
achievable through irradiation with light ranging from 200-800 nm (ultraviolet and visible
light), as seen in Figure 20. It was hypothesized that changes in the UV/Vis spectra of drugs
of abuse attributed to the addition of eumelanin would provide insight into the mechanism
by which drugs and melanin associate.
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Figure 20: Energy diagram of electronic transitions that may occur in organic molecules.
The two lowest energy transitions (i.e., n  π* and π  π*) are the most probable. These
transitions are achievable through irradiation with light ranging from 200 – 800 nm
(ultraviolet and visible light).
6.2 Materials and Methods
Stock solutions of AMP, DZP, MOR, COC were obtained at 1.0 mg/mL in methanol
from Cayman Chemical (Ann Arbor, MI, USA). Δ9-THC was purchased from Cayman
Chemical as 10.0 mg/mL solutions in acetonitrile. These solutions were diluted in methanol
(Fisher Scientific; Hampton, NH, USA) to a final concentration of 100 ng/mL to produce
the working solutions for the titrations. A stock solution of 2 mg/mL of eumelanin (Sigma;
St. Louis, MO, USA) was prepared by first dissolving 2 mg of eumelanin in 500 µL of
DMSO (Fisher Scientific; Hampton NH, USA) and bringing the final volume to 10 mL
with PBS in a volumetric flask.
UV/Visible spectra were recorded on an Agilent Cary 300 UV/Visible
spectrophotometer at 37°C from 350 nm to 190 nm in single beam mode with baseline
correction in quartz cuvettes. Solutions of drug at 1 × 10−4 M were prepared in 1X PBS,

pH 7.4, by adding a volume of the 100 ng/mL stock solution of each analyte. Blank
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solutions used to generate a baseline were prepared by adding a volume of methanol,
consistent with the volume of drug solution added to the analytical samples, to 1X PBS,
pH 7.4. The samples were prepared and analyzed in triplicate, and the λmax was recorded
with its corresponding absorbance value for each analyte. Next, solutions of drug at
1 × 10−4 M were prepared in 1X PBS, pH 7.4, with 0, 0.3, 0.6, 0.9, 1.2, 1.5, 1.8, 2.1, 2.4,
2.7, or 3.0 µg/mL eumelanin. Blank solutions used to generate a baseline were prepared by

adding a volume of methanol consistent with the volume of drug solution added to the
analytical samples and DMSO to achieve a final solution with 5% DMSO. Nine replicate
samples at each concentration of eumelanin were analyzed, and the λmax was recorded with
its corresponding absorbance value for each analyte. These values were plotted against the
concentration of eumelanin as changes in absorbance at the λmax. Data analysis was
performed using OriginLab software (Version 2020).
Additional titration curves were generated using this method while changing the pH
and ionic strength of the buffer to begin to probe the mode of association. The pH of the
buffer was adjusted to 5.5, as to reflect the pH inside hair matrix cells,13 to probe whether
the charge state of ionizable functional groups of the drugs played a role in their association
with eumelanin. The ionic strength of the buffer was increased 10-fold to disrupt ionic
interactions between the drugs and eumelanin to investigate the contribution of ionic
interactions in the association between eumelanin and drugs.
6.3 Results
The λmax of each analyte was recorded (Table 24), and changes at these wavelengths
were observed with the addition of melanin for AMP, COC, and THC. Since the
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absorbance band of the melanin was broadly absorbing with high intensity across the
majority of the visible spectrum and exhibited no change with the addition of drugs, the
changes in the spectra of the drugs were observed with the addition of melanin. The
changes in the presence of melanin were recorded at the λmax of the drug with the addition
of the highest concentration of melanin (3.0 µg/mL). For drugs exhibiting more than one
transition, changes at the highest energy λmax (λmax1) were considered. Addition of
eumelanin to solutions of AMP, COC, and THC produced an increase in the absorbace and
a red shift at λmax 1, whereas there was no significant change in the absorbance at λmax 1 with
DZP and MOR, as seen in Figure 21.
Table 24: Recorded λmax values for Drugs of Abuse
Drug
AMP
COC
THC
DZP
MOR

λmax 1
208
232
209
240
215
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λmax 2
--203
--315
286

λmax 3
--274
-------

Figure 21: Comparison of spectra for solutions containing 1 × 10−4 𝑀𝑀 A: AMP, B: COC,
C: THC, D: DZP, E: MOR in the absence of melanin (black) and in the presence of 3.0
µg/mL melanin (red). Significant increases in the absorbance at the λmax were observed
for AMP, COC, and THC in the presence of melanin, while no significant changes were
seen in the spectra of MOR and DZP in the presence of melanin when compared with
spectra of these drugs in the absence of melanin.
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The titration curves for AMP, COC, and THC were fitted to a linear regression model
(Figure 22) to determine if there were a direct correlation between the changes in the
spectra of the drugs and the addition of melanin. The linear correlation between the change
in absorbance at the λmax and the concentration of melanin was high for AMP and COC,
with R2 values of 0.995 and 0.958, respectively. The correlation between the increase in
absorbance at the λmax of THC and the amount of melanin in solution was lower, with an
R2 value of 0.827.

Figure 22: Linear regressions of the change in λmax values for A: AMP, B: COC, C: THC
with the addition of eumelanin.
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Titration of melanin into drug solutions under different pH and ionic strength
conditions resulted in differences in the change in intensity of the absorbance at the λmax
for both AMP and COC. A Langmuir adsorption model in the form of Equation 3 available
in OriginLab (v. 2020) was used to fit the data to determine the point at which the
association sites of the melanin were saturated with drug, represented by the inflection
point of the Langmuir curve, and the overall change in the absorption at the λmax at the
inflection point to understand the intensity of the influence of the electronic structures in
melanin on those in the drug molecules.
The formula used in the LangmuirEXT1 in OriginLab (v. 2020) fit function is outlined
in Equation 3
𝑎𝑎𝑎𝑎𝑎𝑎1−𝑐𝑐
𝑦𝑦 =
1 + 𝑏𝑏𝑏𝑏1−𝑐𝑐

Equation 3

where y represents qe, a represents qm, b represents KL, and x represents Ce in the Langmuir
equation. The extended model in OriginLab 2020 includes an additional term, c, in the
exponent, which is to account for the potential of multiple binding sites.126 If there is only
one binding site, then the equation reduces to the standard Langmuir equation (Equation
4), ehich is expressed such that Ce (mg·g-1) is the concentration of the adsorbate at
equilibrium, qe is the adsorption capacity at equilibrium, qm is the maximum adsorption
capacity, and KL is the Langmuir constant.127
𝑞𝑞𝑒𝑒 =

𝑞𝑞𝑚𝑚 𝐾𝐾𝐿𝐿 𝐶𝐶𝑒𝑒
1 + 𝐾𝐾𝐿𝐿 𝐶𝐶𝑒𝑒
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Equation 4

A Langmuir model was applied based on the assumption that melanin forms stacks that
have a limited number of interaction sites, namely carboxylic acid moieties and π systems,
on the outer regions of the structures that are exposed in solution for interaction with drugs
in solution. Other assumptions of the Langmuir model are that the surface on which the
adsorption sites exist is homogeneous, the adsorption sites are equivalent, adsorbed
molecules do not interact with one another, all adsorption occurs through the same
mechanism, and at maximum adsorption, a monolayer is formed.128 Since eumelanin stacks
are not a surface in the traditional sense, a monolayer in this system is considered to be
when saturation of the binding sites by drug molecules has been achieved since a limited
number of drug molecules may interact with the melanin stacks depending on the number
of exposed carboxylic acid functions and π systems. The Langmuir model can be used to
simulate a situation in which the melanin surface has reached a monolayer saturation of
drug interacting with the available functions on the exposed regions of the melanin stacks.
Figure 23 shows the increase in the overall intensity of the absorbance at the λmax of
AMP at the inflection point of the Langmuir curve at pH 5.5 (ΔABS = 0.45) when
compared to that at pH 7.4 (ΔABS = 0.23). At pH 5.5, after a 10-fold increase in the ionic
strength of the PBS buffer, the overall change in intensity of absorbance at the λmax at the
inflection point of the Langmuir curve decreased from ΔABS = 0.45 to ΔABS = 0.39
(Figure 24). The inflection point at the higher pH corresponded with a higher concentration
of melanin at 10 µg/mL when compared to the lower pH, where the inflection point
corresponded with 3 µg/mL of melanin.
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Figure 23: Langmuir fit of change in the intensity of absorbance at 208 nm with the
addition of melanin to solutions with AMP at pH 7.4 (red) and 5.5 (blue).
At pH 5.5, after a 10-fold increase in the ionic strength of the PBS buffer, the overall
change in intensity of absorbance at the λmax at the inflection point of the Langmuir curve
decreased from ΔABS = 0.45 to ΔABS = 0.39 (Figure 24). Also, the inflection point in the
10X buffer occurred at about 25 µg/ mL of melanin, where the inflection point at the lower
ionic strength was at 10 µg/ mL of melanin.
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Figure 24: Langmuir fit of change in the intensity of absorbance at 208 nm with the
addition of melanin to solutions with AMP at pH 5.5 in 1X PBS buffer (red) and 10X PBS
buffer (blue).
The difference in the change in the absorbance at the inflection point of the Langmuir
curve at different pH values was more dramatic for COC in the presence of melanin, such
that at pH 7.4 the absorbance was 0.78 and at pH 5.5 it was 0.14 (Figure 25). The inflection
point of the Langmuir curve occurs at approximately the same concentration of melanin,
10 µg/mL, added under both pH conditions.
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Figure 25: Langmuir fit of change in the intensity of absorbance at the λmax of cocaine
with the addition of melanin to solutions with COC at pH 7.4 (red) and 5.5 (blue).
At pH 7.4, the change in the absorbance at the inflection point of the Langmuir curve
was 0.03 at high ionic strength of the buffer, whereas at lower ionic strength the change
was 0.78 (Figure 26). The inflection point of the curve occurred at a lower concentration
of melanin, 10 µg/mL, at the lower ionic strength compared to the 50 µg/mL of melanin at
the higher ionic strength.

110

Figure 26: Langmuir fit of change in the intensity of absorbance at 214 nm with the
addition of melanin to solutions with COC at pH 7.4 in 1X PBS buffer (red) and 10X PBS
buffer (blue).
The association constant was obtained in Origin 2020 from the Langmuir curves using
the value reported for the b parameter of the fit as outlined in Equation 3, and are reported
in Table 25. The association constant for AMP was reported for the Langmuir curve
generated from AMP and melanin together in a 1X PBS buffer at pH 5.5, as these
conditions were associated with the greatest change in the AMP spectra. The greatest
increase in absorbance at the λmax of COC occurred in 1X PBS buffer at pH 7.4; therefore
the association constant reported in Table 25 for COC is from the Langmuir curve resulting
from these conditions. The association constant determined for COC with melanin, 1.23 ±

0.2 × 106, was consistent with Shimada et al. who observed an association constant of
8.9 × 105 M-1. The association constant of AMP with melanin, 5.4 ± 0.4 × 105 M-1, was between

the values reported by Simiada et al. and Borges et al. The trend in the three datasets remains the
same in that COC has a higher affinity for melanin than AMP.
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Table 25: Comparison of association constants for eumelanin and drugs.
Compound
AMP
COC

KL (M-1)
from the present
work
5.4 ± 0.4 × 105
1.23 ± 0.2 × 106

Ka previously reported
(M-1) 16

Ka previously
reported (M-1)4

(+) AMP: 2.8 × 105
(-) AMP: 2.6 × 105
8.9 × 105

1.6 × 106
4.0 × 106

6.4 Discussion
The λmax of benzene is 203.5 nm, and is associated with the conjugated π electrons of
the system.125 When electron-donating functions, such as alkyl chains and more extensive
π-conjugated systems, are covalently bound to benzene a bathochromic shift is observed in
the 203.5 nm absorbance maximum.125 Therefore, for each of the analytes in this study, the
λmax 1 values are likely associated with the π electrons in the aromatic rings, as they are all
similar to the λmax of benzene. The bathochromic shifts observed in the λmax 1, as compared
to benzene, of each of the analytes is consistent with the more complex structures of the
drugs as compared to benzene. The increase in the absorbance of the λmax 1 peak in the UV
spectra of the tested analytes in the presence of melanin suggests that the interaction
between the analytes and melanin is related to van der Waals forces between the π systems
of the aromatic rings present in each of the analytes and in the structure of eumelanin as
has been reported in literature.125
It has been theorized that analytes that are cationic at physiological pH interact with
the anionic carboxylic acids of the melanin polymer; the interaction between drugs and
melanin can be strengthened by van der Waals forces between aromatic rings in drug
molecules and the aromatic indole rings of melanin.23 The pKa values for AMP and COC
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are 9.9 and 8.6 respectively. While virtually all AMP is cationic under both pH conditions,
COC is 100% cationic at pH 5.5 and >50% cationic at pH 7.4. It is reasonable to
hypothesize an interaction of these cations with the carboxylic acid moieties of eumelanin.
The pKa of the carboxylic acid moieties is around 5.0; therefore, at pH 5 only a small
fraction of the carboxylic acids was anionic and at pH 7.4 100% of the carboxylic acids
were anionic. As previously suggested, these electrostatic interactions can be envisioned
to be stabilized by van der Waals forces between the aromatic π systems of the drug
molecules and the eumelanin. This explains the bathochromic shift in the λmax of the drug
molecules in the presence of melanin.125 Evidence of ionic interactions between eumelanin
and COC and AMP is further supported by the fact that the inflection point of the Langmuir
curve was associated with greater concentrations of melanin under high ionic strength
conditions. This finding suggests that the increased concentration of ions in solution
necessitated higher concentrations of melanin for the drugs to saturate the sites for
interaction on melanin; thus the buffer salts may have disrupted the ionic interactions
between the drugs and melanin.
Since THC lacks an amine function, but was seen to interact with melanin, electrostatic
interactions cannot be the only means by which drugs interact with eumelanin. These
interactions are likely stabilized by van der Waals forces between the aromatic π systems
of the drug molecules and the eumelanin, as previously suggested, which is evident from
the bathochromic shift in the λmax THC, COC, and AMP in the presence of melanin.125
Though correlation was observed between the change in the spectra of THC, AMP, and
COC with the addition of melanin, it is important to note that there are factors, other than
melanin concentration, that may affect the spectra. Solvent effects may be partially
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responsible for the changes in the spectra. Specifically, when the pH conditions were
changed, the identity of the species in solution were not confirmed, thus the changes in
spectra could be a result of the hydrolysis of the species in solution (i.e., ester groups of
drug molecules and/or quinones of eumelanin). However, there were changes in the
absorbance at the λmax of the drug with increasing concentrations of eumelanin, supporting
the conclusion that the species in solution may be interacting.
The differences in the exact values of the association constants is attributed to the two
different buffers used in these two studies by Borges et al., who used a formic acid and
ammonium formate buffer system in the LC-MS experiments with a pH of 3.8 and Shimada
et al. used a PBS buffer at a pH of 7.4 with a greater ionic strength that that used by Borges
et al.4,16 The results reported herein used different pH and ionic strength conditions to
accommodate for the conditions under which each analyte and melanin interacted most
significantly. The conditions under which COC were studied were the same in this work
as in Shimada et al., which is likely why there is good agreeance between the results. The
pH of the buffer in the present work was adjusted to 5.5 for the study of the interactions
between AMP and melanin, which may explain why the affinity was higher in the present
study. Additionally, Shimada et al. studied the enantiomers of AMP separately, where a
racemic mixture was used in the present work.
6.5 Conclusions
The changes in the UV/Vis spectra of THC, COC, and AMP indicated that van der
Waals forces and electrostatic interactions likely work in tandem to influence a drug
molecule’s affinity for melanin. A direct correlation between the addition of melanin to
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solutions of COC and AMP was observed, whereas the correlation was less significant with
THC. The structural differences between these drug molecules supports the hypothesis that
the van der Waals forces between π systems in melanin and drug molecules can allow for
associations. These relatively weak forces can be supported by much stronger electrostatic
forces, as between charged amines and carboxylic acids, to further strengthen the
interaction. Since some drugs, like COC and AMP, interact with melanin more directly
than others, like THC, these compounds are more likely to accumulate in hair that has
darker brown/black pigment, which results in a bias in hair testing. It is important to follow
the present work with additional spectroscopic techniques that allow for a more direct
observation of the hypothesized interaction between drug molecules and eumelanin, as
UV/Visible spectroscopy is a non-specific technique that is susceptible to solvent effects.
Additionally, computational approximations of the interactions are necessary to understand
the energy changes in the HOMO and LUMO when the analytes are solvated and mixed
with eumelanin. Understanding these associations may allow for changes in the routine
analysis of hair to include standardizing the concentrations of drugs known to more
strongly associate with eumelanin to the hair’s eumelanin content.
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7. SUMMARY AND PROSPECTUS
The lack of consensus regarding optimal techniques for the toxicological analysis of
hair has resulted in a large literature base from which it is impossible to discern which
techniques are the most effective for routine analysis. As toxicological hair analysis can be
permissible evidence in court, it is imperative that specific guidelines are formed regarding
the workflow necessary for the results and the interpretation of those results to be reliable
evidence. Thus, the goals of this work were to investigate the efficacy of a variety of pretreatment parameters for select drugs of abuse to work toward the standardization of
forensic toxicological analysis of hair and to investigate the interactions between these
analytes and eumelanin.
It has been concluded that decontamination parameters require special attention for
analytes with different physical and chemical properties, such that it is impossible to
determine a priori which combinations of solvents/solutions, number of consecutive
washes, and length of wash steps are necessary to effectively remove surface
contamination. Solvent extraction was the most effective technique for extracting a variety
of analytes from the hair matrix. Insight into the efficacy of various methodologies may
also be achieved by further understanding of the mechanisms by which drugs are held in
hair. Spectroscopic studies suggested that interactions between eumelanin and drug
molecules are strongest when electrostatic and van der Waals forces are both possible
simultaneously, supporting literature suggesting the presence of an ionizable amine in the
drug molecule increases its eumelanin affinity because it is capable of interacting with
anionic carboxylic acids on eumelanin structures.
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Future work should include similar studies involving the effect of pre-treatment
parameters and the association mechanisms regarding metabolites of drugs in hair.
Additional work applying DoE methods to authentic HRM and, ultimately, to authentic
specimens would help to elucidate if the conclusions made regarding pre-treatment
parameters using incorporated/entrapped HRM are applicable to real samples. Additional
DoE studies including other parameters known to effect the results of hair analysis, like
the use of ultrasonication during extraction, that were not addressed in this work should be
studied. Also, additional levels of parameters should be investigated by DoE, for example
other decontamination solvents/solutions, such as isopropanol and buffers. Spectroscopic
techniques that provide more structural information, such as 1H NMR and mass
spectrometry, should be explored to further probe the interactions between drugs and
eumelanin.
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APPENDICES
Appendix 1. Biosynthetic pathways for eumelanin and pheomelanin.21
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Appendix 2. Analytical method development and validation.
Solid Phase Extraction
For cleanup of hair extracts, Agilent Bond Elut Certify mixed mode cartridges are used
following a method characterized for hair samples by Miller et al.101 Determination of the
recovery and matrix effects using this SPE method required the preparation of three sets of
samples. Set 1 consisted of neat drug, at 100 ng/mL, in methanol. Sets 2 and 3 required the
presence of sample matrix.129Thus, sets of 30 mg of blank hair were degraded with each of
the extraction techniques previously described. Set 2 was prepared by submitting the
degraded matrix to SPE and subsequently spiking the reconstituted solution with drug at
100 ng/mL. Set 3 were spiked with 100 ng/mL of drug before submitting them to SPE. LCQqQ analysis allowed for the determination of the peak area of the drug. Relationships of
the peak areas from the different sample sets were used to characterize the performance of
the SPE protocol. The recovery was determined by Equation 5.129 Matrix effects were
calculated for each extraction technique using Equation 6.129

𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 =

𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 =

𝑠𝑠𝑠𝑠𝑠𝑠 3
× 100
𝑠𝑠𝑠𝑠𝑠𝑠 1

𝑠𝑠𝑠𝑠𝑠𝑠 1 − 𝑠𝑠𝑠𝑠𝑠𝑠 2
× 100
𝑠𝑠𝑠𝑠𝑠𝑠 2
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Equation 5

Equation 6

Accuracy and Precision
The accuracy and precision measures for amphetamine and diazepam met SWGTOX
requirements, as seen in Table 26. 130 The relative standard deviation was below 20% for
all concentrations of each analyte. The accuracy fell within ± 20% of the spiked
concentration for all concentrations of both drugs.
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Table 26: Accuracy and Precision Measures
Compound

AMP

DZP

THC

COC

MOR

HER

0.3

0.9

0.1

0.4

0.03

0.3

RSD (%)

6.5

16.6

2.1

8.0

0.63

6.0

Accuracy

98

108

91

97

110

92

1

2

0.5

1

0.9

0.9

RSD (%)

2

3

0.6

1

1.2

1.1

Accuracy

101

98

100

100

99

100

5

4

4

3

3

0.7

RSD (%)

2

2

2

1

1

0.3

Accuracy

100

102

102

99

100

101

Concentration

5

Standard

(ng/mL)

(n=5)

Deviation
(ng/mL)

(%)
75

Standard

(n=5)

Deviation
(ng/mL)

(%)
250

Standard

(n=5)

Deviation
(ng/mL)

(%)
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Recovery
The SPE protocol used was previously applied to a variety of compounds in standard
solutions, including amphetamine, diazepam, cocaine, morphine, and the major
metabolites of these drugs in hair. Miller et al. observed 99.6 ± 6.0% recovery of

amphetamine, 98.3± 2.1% recovery of diazepam, 97.3 ± 3.1% recovery of cocaine, and

92.3± 1.1% recovery of morphine using this method. Table 27 shows the recoveries

obtained for these compounds (n=3) and HER and THC using the Bond Elut Certify
method used by Miller et al. Recoveries observed were comparable to those previously
reported and complied with SWGTOX guidelines of 100 ±20%.

Table 27: Recovery of Analytes Using the Bond Elut Certify Method
Compound

Initial

% Recovery

Concentration
(ng/mL)
AMP

98 ± 2

DZP

94 ± 2

THC
COC

100

MOR

111 ± 19
98 ± 12
94 ± 15

HER

93 ± 13
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Matrix Effects
Matrix effects obtained, Table 28, were comparable to those reported by Miller et al.
and complied with SWGTOX guidelines. The matrix effects were reported as 96.4±13.7%
for COC, 85.4±11.1% for MOR, 95.5±13.9% for DZP, 97.9±3.4% for AMP.
Table 28: Matrix effects observed for each analyte under enzymatic degradation and
solvent extraction conditions
Extraction Technique

AMP

DZP

THC

COC

MOR

HER

Enzymatic Degradation

105%

97% 111%

97%

88%

89%

Solvent Extraction

111%

94% 119%

92%

82%

83%

HPLC -QqQ Analysis
For drug analysis, 1 µL of each isolate was injected onto a reversed-phase liquid
chromatography column and subsequently analyzed by QqQ-MS/MS. The compounds
were separated using a 1.8 µm Zorbax Eclipse Plus C18 rapid resolution HD column (2.1 x
150 mm) from Agilent. The aqueous mobile phase used was water with 0.1% formic acid
and 5 mM ammonium formate. The organic phase was MeOH with 0.1% formic acid. The
separation was conducted using a gradient solvent system such that the relative percentages
of the aqueous and organic phases varied over the time of analysis. The gradient was as
follows: at 0 min the mobile phase was a 95% aqueous and 5% organic mixture, from 0 to
5 min the gradient adjusted to 100% organic mobile phase, from 5 to 8 min the gradient
was held at 100% organic to flush the column. The mobile phase flow rate was 0.3 mL/min.
Gradient elution resulted in a LC-QqQ method that allowed for baseline resolution of the
compounds of interest.
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An LC-QqQ-MS multiple reaction monitoring (MRM) method was used for the
identification of analytes. The peaks were confirmed by MRM transitions corresponding
to the integrated peak. MRM peaks were specified in the LC-MS method based on the two
most abundant transitions, one as a quantifier and the other as a qualifier. These transitions
were identified by Agilent’s MassHunter Optimizer program and are listed in Table 29.
The data was acquired in Agilent MassHunter Qualitative software. The spectral peak
areas were integrated, and the data files were then uploaded in to the MassHunter
Quantitative software.
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Table 29: MRM Transitions Selected for LC-QqQ Method
Compound Name

MRM Transition(s)
Precursor Ion (m/z) Product Ion (m/z)

AMP

136

119
91

AMP-D11

147

98

COC

304

182
82

COC-D3

307

185

DZP

285

222
193

DZP-D5

290

193

MOR

286

201
155

MOR-D3

289

126

HER

370

211
165

THC

315

193
123

THC-D3

318

143
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A calibration curve was generated using drug standards purchased from Cerilliant with
a 1 mg/mL concentration and the corresponding deuterated compound. The drug standards
were diluted in MeOH to a final volume of 500 µL to generate calibration solutions with
250, 200, 150, 75, 35, 15, 5, and 1 ng/mL concentrations. The calibrators also had a
concentration of 100 ng/mL of deuterated internal standard.

Figure 27: LC separation (from left to right) of morphine, amphetamine, cocaine, heroin,
diazepam, and Δ9-tetrahydrocannabinol at 75 ng/mL. The MRM spectrum of the six
separated substances, showing two unique transitions for each and labeled with their
respective retention times.
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